Every Notice of Compliance Health Canada issued for a new drug submission since 2016, and for a generic drug in the last 24 months. Human medicines only.
Health Canada issued 99 Notices of Compliance for new drug submissions in the last 12 months, 42 of them for a new active substance and 9 under priority review, plus 148 for generics. The most recent new active substance was Ammivo (Sterimax Inc) on 16 Sep 2026. A Notice of Compliance is Health Canada's authorisation to market a drug in Canada.
| Product | Company | Type | Notice |
|---|---|---|---|
| AMMIVO Sodium Benzoate, Sodium Phenylacetate |
Sterimax Inc | Prescription Pharmaceutical Priority-NAS |
16 Sep 2026 NOC 38296 |
| METHOHEXITAL SODIUM FOR INJECTION USP Methohexital Sodium |
Sterimax Inc | Prescription Pharmaceutical Other |
14 Sep 2026 NOC 38285 |
| PERIDEX ORAL RINSE Chlorhexidine Gluconate 3 clinical trials → |
Solventum Canada Limited | Prescription Pharmaceutical Labelling Only |
4 Sep 2026 NOC 38243 |
| QOSEQU Denosumab 23 clinical trials → |
Mantra Pharma Inc. | Biologic Other |
12 Aug 2026 NOC 38100 |
| GALANTAMINE ER Galantamine Hydrobromide 2 clinical trials → |
Essential Pharma Switzerland Gmbh | Prescription Pharmaceutical Labelling Only |
11 Aug 2026 NOC 38099 |
| ETCAMAH Camizestrant 13 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
4 Aug 2026 NOC 38047 |
| AMBELVIST Gadoquatrane |
Bayer Inc | Prescription Pharmaceutical New Active Substance (NAS) |
29 Jul 2026 NOC 38008 |
| RHAPSIDO Remibrutinib 18 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
16 Jul 2026 NOC 37930 |
| OJEMDA Tovorafenib 6 clinical trials → |
Ipsen Biopharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
13 Jul 2026 NOC 37901 |
| ODENSIFY Denosumab 23 clinical trials → |
Jamp Pharma Corporation | Biologic Other |
10 Jul 2026 NOC 37880 |
| XDENO Denosumab 23 clinical trials → |
Jamp Pharma Corporation | Biologic Other |
10 Jul 2026 NOC 37879 |
| GABAPENTIN ORAL SOLUTION Gabapentin 9 clinical trials → |
Rubicon Research Canada Limited | Prescription Pharmaceutical Other |
10 Jul 2026 NOC 37874 |
| SCENESSE Afamelanotide Acetate |
Clinuvel, Inc. | Prescription Pharmaceutical New Active Substance (NAS) |
9 Jul 2026 NOC 37875 |
| JOENJA Leniolisib Phosphate 4 clinical trials → |
Pharming Technologies B.v. | Prescription Pharmaceutical Priority-NAS |
8 Jul 2026 NOC 37862 |
| VANRAFIA Atrasentan Hydrochloride 3 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
2 Jul 2026 NOC 37820 |
| BESREMI Ropeginterferon Alfa-2b |
Forus Therapeutics Inc | Biologic New Active Substance (NAS) |
2 Jul 2026 NOC 37818 |
| IDARUBICIN Idarubicin Hcl 13 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical Labelling Only |
30 Jun 2026 NOC 37815 |
| VIMKUNYA Chikungunya Virus Virus-like Particle |
Bavarian Nordic As | Nonprescription Pharmaceutical New Active Substance (NAS) |
26 Jun 2026 NOC 37777 |
| BOEY Trenibotulinumtoxine |
Abbvie Corporation | Prescription Pharmaceutical New Active Substance (NAS) |
22 Jun 2026 NOC 37735 |
| EPYSQLI Eculizumab 12 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
17 Jun 2026 NOC 37727 |
| EXDENSUR Depemokimab 10 clinical trials → |
Glaxosmithkline Inc | Biologic New Active Substance (NAS) |
15 Jun 2026 NOC 37709 |
| PIMJETMI Pimicotinib Hydrochloride 7 clinical trials → |
Emd Serono A Division Of Emd Inc Canada | Prescription Pharmaceutical Priority-NAS |
12 Jun 2026 NOC 37708 |
| LUPIN-GLUCAGON Glucagon 2 clinical trials → |
Lupin Pharma Canada Limited | Prescription Pharmaceutical Other |
10 Jun 2026 NOC 37689 |
| RANVU Ranibizumab 13 clinical trials → |
Apotex Inc | Biologic Other |
10 Jun 2026 NOC 37685 |
| IDVYNSO Doravirine, Islatravir |
Merck Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
3 Jun 2026 NOC 37657 |
| LOARGYS Pegzilarginase |
Immedica Pharma Ab | Biologic Priority-NAS |
29 May 2026 NOC 37628 |
| THYCONVI Levothyroxine Sodium 7 clinical trials → |
Biosyent Pharma Inc | Prescription Pharmaceutical Other |
15 May 2026 NOC 37564 |
| IHEEZO Chloroprocaine Hydrochloride |
Apotex Inc | Prescription Pharmaceutical Other |
14 May 2026 NOC 37565 |
| KISUNLA Donanemab 9 clinical trials → |
Eli Lilly Canada Inc | Biologic New Active Substance (NAS) |
30 Apr 2026 NOC 37446 |
| BEVQOLVA Bevacizumab 400 clinical trials → |
Curateq Biologics Private Limited | Biologic Other |
28 Apr 2026 NOC 37450 |
| BEKEMV Eculizumab 12 clinical trials → |
Amgen Canada Inc | Biologic Other |
22 Apr 2026 NOC 37454 |
| CONEXXENCE Denosumab 23 clinical trials → |
Fresenius Kabi Canada Ltd | Biologic Other |
18 Apr 2026 NOC 37445 |
| BOMYNTRA Denosumab 23 clinical trials → |
Fresenius Kabi Canada Ltd | Biologic Other |
18 Apr 2026 NOC 37444 |
| VEVZUO Denosumab 23 clinical trials → |
Biosimilar Collaborations Ireland Limited | Biologic Other |
17 Apr 2026 NOC 37456 |
| BOSAYA Denosumab 23 clinical trials → |
Biosimilar Collaborations Ireland Limited | Biologic Other |
17 Apr 2026 NOC 37455 |
| TEVIMBRA Tislelizumab 259 clinical trials → |
Beone Medicines I Gmbh | Biologic Other |
16 Apr 2026 NOC 37417 |
| OBODENCE Denosumab 23 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
13 Apr 2026 NOC 37340 |
| LUNSUMIO SC Mosunetuzumab 20 clinical trials → |
Hoffmann-la Roche Limited | Biologic Other · with conditions |
10 Apr 2026 NOC 37489 |
| UPGOLYV Golimumab 6 clinical trials → |
Jamp Pharma Corporation | Biologic Other |
10 Apr 2026 NOC 37311 |
| VUEWAY Gadopiclenol 2 clinical trials → |
Bracco Imaging Canada | Prescription Pharmaceutical New Active Substance (NAS) |
10 Apr 2026 NOC 37310 |
| NEFFY Epinephrine 10 clinical trials → |
Alk- Abello A/s | Prescription Pharmaceutical Other |
9 Apr 2026 NOC 37319 |
| YEYTUO Lenacapavir Sodium 17 clinical trials → |
Gilead Sciences Canada Inc | Prescription Pharmaceutical Other |
9 Apr 2026 NOC 37292 |
| CAMCEVI Leuprolide Mesylate 10 clinical trials → |
Accord Healthcare Inc | Prescription Pharmaceutical Other |
31 Mar 2026 NOC 37236 |
| XBRYK Denosumab 23 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
30 Mar 2026 NOC 37229 |
| DENOZA Denosumab 23 clinical trials → |
Apotex Inc | Biologic Other |
23 Mar 2026 NOC 37160 |
| ODAN-ARIPIPRAZOLE SOLUTION Aripiprazole 7 clinical trials → |
Odan Laboratories Ltd | Prescription Pharmaceutical Other |
18 Mar 2026 NOC 37136 |
| ADSTILADRIN Nadofaragene Firadenovec 3 clinical trials → |
Ferring Inc | Biologic New Active Substance (NAS) |
16 Mar 2026 NOC 37129 |
| CLOBIVIS Clobetasol Propionate 3 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Other |
13 Mar 2026 NOC 37105 |
| IDENOS Denosumab 23 clinical trials → |
Apotex Inc | Biologic Other |
11 Mar 2026 NOC 37133 |
| TUZEMTY Denosumab 23 clinical trials → |
Shanghai Henlius Biotech, Inc. | Biologic Other |
9 Mar 2026 NOC 37155 |
| BILDYOS Denosumab 23 clinical trials → |
Shanghai Henlius Biotech, Inc. | Biologic Other |
9 Mar 2026 NOC 37095 |
| CYSKLAR Cysteamine Hydrochloride |
Leadiant Biosciences, Inc. | Prescription Pharmaceutical Other |
6 Mar 2026 NOC 37062 |
| BALANSYA Escitalopram Oxalate |
Orimed Pharma Inc | Prescription Pharmaceutical Other |
4 Mar 2026 NOC 37035 |
| MINT-CITALOPRAM SOLUTION Citalopram Hydrobromide 2 clinical trials → |
Mint Pharmaceuticals Inc | Prescription Pharmaceutical Other |
25 Feb 2026 NOC 36967 |
| ADRUXE Rituximab 239 clinical trials → |
Dr. Reddy's Laboratories Sa | Biologic Other |
13 Feb 2026 NOC 37043 |
| RIFAPENTINE TABLETS Rifapentine 3 clinical trials → |
Macleods Pharmaceuticals Limited | Prescription Pharmaceutical New Active Substance (NAS) |
12 Feb 2026 NOC 36895 |
| LUNSUMIO Mosunetuzumab 20 clinical trials → |
Hoffmann-la Roche Limited | Biologic New Active Substance (NAS) · with conditions |
6 Feb 2026 NOC 36883 |
| ENFLONSIA Clesrovimab |
Merck Canada Inc | Biologic New Active Substance (NAS) |
30 Jan 2026 NOC 36842 |
| RECARBRIO Imipenem, Cilastatin Sodium, Relebactam |
Merck Canada Inc | Prescription Pharmaceutical Priority-NAS |
30 Jan 2026 NOC 36807 |
| HYRNUO Sevabertinib 2 clinical trials → |
Bayer Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
29 Jan 2026 NOC 36802 |
| YORVIPATH Palopegteriparatide 2 clinical trials → |
Pendopharm Division Of Pharmascience Inc | Biologic New Active Substance (NAS) |
28 Jan 2026 NOC 36796 |
| VOXZOGO Vosoritide 9 clinical trials → |
Biomarin International Limited | Biologic New Active Substance (NAS) · with conditions |
21 Jan 2026 NOC 36762 |
| ZIIHERA Zanidatamab 14 clinical trials → |
Jazz Pharmaceuticals Ireland Limited | Biologic New Active Substance (NAS) · with conditions |
15 Jan 2026 NOC 36774 |
| IMULDOSA, IMULDOSA IV Ustekinumab 25 clinical trials → |
Accord Healthcare Inc | Biologic Other |
12 Jan 2026 NOC 36767 |
| DYRUPEG Pegfilgrastim 18 clinical trials → |
Curateq Biologics Private Limited | Biologic Other |
6 Jan 2026 NOC 37162 |
| REDEMPLO Plozasiran 4 clinical trials → |
Arrowhead Pharmaceuticals, Inc. | Prescription Pharmaceutical Priority-NAS |
2 Jan 2026 NOC 36679 |
| JERAYGO Aprocitentan |
Idorsia Pharmaceuticals Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
23 Dec 2025 NOC 36630 |
| PLOSBRIO Semaglutide 110 clinical trials → |
Novo Nordisk Canada Inc | Biologic Labelling Only |
22 Dec 2025 NOC 36610 |
| POVIZTRA Semaglutide 110 clinical trials → |
Novo Nordisk Canada Inc | Biologic Labelling Only |
22 Dec 2025 NOC 36609 |
| NEMLUVIO Nemolizumab 6 clinical trials → |
Galderma Canada Inc | Biologic New Active Substance (NAS) |
18 Dec 2025 NOC 36596 |
| TEVIMBRA Tislelizumab 259 clinical trials → |
Beone Medicines I Gmbh | Biologic New Active Substance (NAS) |
18 Dec 2025 NOC 36584 |
| TRYNGOLZA Olezarsen Sodium 4 clinical trials → |
Theratechnologies Inc | Prescription Pharmaceutical Priority-NAS |
16 Dec 2025 NOC 36553 |
| JATENZO (TESTOSTERONE UNDECANOATE) Testosterone Undecanoate 2 clinical trials → |
Tolmar International Ltd. | Prescription Pharmaceutical Other |
12 Dec 2025 NOC 36536 |
| ELFABRIO Pegunigalsidase Alfa 3 clinical trials → |
Chiesi Farmaceutici S.p.a. | Biologic New Active Substance (NAS) |
9 Dec 2025 NOC 36501 |
| IMAAVY Nipocalimab 12 clinical trials → |
Janssen Inc | Biologic New Active Substance (NAS) |
5 Dec 2025 NOC 36540 |
| SEPTRA PEDIATRIC ORAL SUSPENSION Sulfamethoxazole, Trimethoprim |
Aspen Pharmacare Canada Inc. | Prescription Pharmaceutical Labelling Only |
5 Dec 2025 NOC 36503 |
| ZURZUVAE Zuranolone |
Biogen Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
5 Dec 2025 NOC 36489 |
| TWYNEO Benzoyl Peroxide, Tretinoin |
Searchlight Pharma Inc | Prescription Pharmaceutical Other |
4 Dec 2025 NOC 36482 |
| LATANEO PF Latanoprost |
Orimed Pharma Inc | Prescription Pharmaceutical Other |
2 Dec 2025 NOC 36464 |
| EYDENZELT Aflibercept 42 clinical trials → |
Celltrion Inc | Biologic Other |
24 Nov 2025 NOC 36435 |
| WYNZORA Betamethasone Dipropionate, Calcipotriol |
Knight Therapeutics Inc. | Prescription Pharmaceutical Other |
21 Nov 2025 NOC 36413 |
| AHZANTIVE Aflibercept 42 clinical trials → |
Valorum Biologics Llc | Biologic Other |
19 Nov 2025 NOC 36404 |
| NILEMDO Bempedoic Acid 7 clinical trials → |
Hls Therapeutics Inc | Prescription Pharmaceutical New Active Substance (NAS) |
14 Nov 2025 NOC 36375 |
| KYZATREX Testosterone Undecanoate 2 clinical trials → |
Marius Pharmaceuticals, Llc | Prescription Pharmaceutical Other |
10 Nov 2025 NOC 36353 |
| RETEVMO Selpercatinib 13 clinical trials → |
Eli Lilly Canada Inc | Prescription Pharmaceutical Labelling Only · with conditions |
6 Nov 2025 NOC 36338 |
| ENZEEVU Aflibercept 42 clinical trials → |
Sandoz Canada Incorporated | Biologic Other |
30 Oct 2025 NOC 36288 |
| DOXYCYCLINE FOR INJECTION USP Doxycycline Hyclate 10 clinical trials → |
Sterimax Inc | Prescription Pharmaceutical Other |
28 Oct 2025 NOC 36268 |
| LEQEMBI Lecanemab 13 clinical trials → |
Eisai Limited | Biologic New Active Substance (NAS) · with conditions |
24 Oct 2025 NOC 36245 |
| YESINTEK, YESINTEK I.V. Ustekinumab 25 clinical trials → |
Biosimilar Collaborations Ireland Limited | Biologic Other |
17 Oct 2025 NOC 37167 |
| LOQTORZI Toripalimab 168 clinical trials → |
Apotex Inc | Biologic New Active Substance (NAS) |
17 Oct 2025 NOC 36209 |
| JAYPIRCA Pirtobrutinib 31 clinical trials → |
Eli Lilly Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
17 Oct 2025 NOC 36204 |
| NITROJECT Nitroglycerin 6 clinical trials → |
Juno Pharma Canada Inc. | Prescription Pharmaceutical Labelling Only |
17 Oct 2025 NOC 36200 |
| AVTOZMA Tocilizumab 71 clinical trials → |
Celltrion Inc | Biologic Other |
16 Oct 2025 NOC 36201 |
| LYVDELZI Seladelpar Lysine |
Gilead Sciences Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
16 Oct 2025 NOC 36189 |
| AA-VERAP Verapamil Hcl 4 clinical trials → |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
14 Oct 2025 NOC 36298 |
| OPUVIZ Aflibercept 42 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
9 Oct 2025 NOC 36207 |
| SEPHIENCE Sepiapterin |
Ptc Therapeutics International Limited | Prescription Pharmaceutical Priority-NAS |
7 Oct 2025 NOC 36125 |
| MNEXSPIKE Mrna Encoding Sars-cov-2 Spike Protein Ntd-rbd Subdomains |
Moderna Biopharma Canada Corporation | Biologic New Active Substance (NAS) |
29 Sep 2025 NOC 36079 |
| AGAMREE Vamorolone 2 clinical trials → |
Kye Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS |
29 Sep 2025 NOC 36073 |
| TYRUKO Natalizumab 3 clinical trials → |
Polpharma Biologics S.a. | Biologic Other |
24 Sep 2025 NOC 36056 |
| OSENVELT Denosumab 23 clinical trials → |
Celltrion Inc | Biologic Other |
17 Sep 2025 NOC 36027 |
| STOBOCLO Denosumab 23 clinical trials → |
Celltrion Inc | Biologic Other |
17 Sep 2025 NOC 36026 |
| ORITINIV Oritavancin Phosphate |
Xediton Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS |
12 Sep 2025 NOC 36018 |
| SLENYTO Melatonin 23 clinical trials → |
Neurim Pharmaceuticals Ltd. | Prescription Pharmaceutical Other |
8 Sep 2025 NOC 35971 |
| ACCUTANE Isotretinoin 8 clinical trials → |
Cheplapharm Schweiz Gmbh | Prescription Pharmaceutical Labelling Only |
5 Sep 2025 NOC 35975 |
| ELAHERE Mirvetuximab Soravtansine 9 clinical trials → |
Abbvie Corporation | Biologic Priority-NAS |
29 Aug 2025 NOC 35928 |
| EPSOLAY Benzoyl Peroxide |
Searchlight Pharma Inc | Prescription Pharmaceutical Other |
27 Aug 2025 NOC 35909 |
| ANZUPGO Delgocitinib 4 clinical trials → |
Leo Pharma Inc | Prescription Pharmaceutical New Active Substance (NAS) |
25 Aug 2025 NOC 35893 |
| ODAN-PREGABALIN Pregabalin 27 clinical trials → |
Odan Laboratories Ltd | Prescription Pharmaceutical Other |
19 Aug 2025 NOC 35864 |
| AMTAGVI Lifileucel 4 clinical trials → |
Iovance Biotherapeutics, Inc | Biologic New Active Substance (NAS) · with conditions |
15 Aug 2025 NOC 35846 |
| ADVIL ARTHRITIS PAIN, ADVIL EXTRA STRENGTH LIQUI-GELS, ADVIL LIQUI-GELS, ADVIL MIGRAINE & HEADACHE Ibuprofen 22 clinical trials → |
Haleon Canada Ulc | Nonprescription Pharmaceutical Labelling Only |
14 Aug 2025 NOC 35829 |
| HEPCLUDEX Bulevirtide Acetate 7 clinical trials → |
Gilead Sciences Canada Inc | Prescription Pharmaceutical Priority-NAS |
8 Aug 2025 NOC 35802 |
| ANDEMBRY Garadacimab |
Csl Behring Canada Inc | Biologic New Active Substance (NAS) |
6 Aug 2025 NOC 35821 |
| CYCLOPHOSPHAMIDE FOR INJECTION Cyclophosphamide 356 clinical trials → |
Dr Reddys Laboratories Ltd | Prescription Pharmaceutical Other |
5 Aug 2025 NOC 35794 |
| DYANAVEL XR Amphetamine Aspartate Monohydrate, Mixed Salts Amphetamine, Amphetamine |
Kye Pharmaceuticals Inc | Prescription Pharmaceutical Other |
28 Jul 2025 NOC 35754 |
| LYNKUET Elinzanetant |
Bayer Inc | Prescription Pharmaceutical New Active Substance (NAS) |
23 Jul 2025 NOC 35723 |
| BUCCOLAM Midazolam Hydrochloride 58 clinical trials → |
Neuraxpharm Pharmaceuticals, S.l. | Prescription Pharmaceutical Other |
22 Jul 2025 NOC 35718 |
| BLENREP Belantamab Mafodotin 24 clinical trials → |
Glaxosmithkline Inc | Biologic Other |
21 Jul 2025 NOC 35725 |
| ALYFTREK Tezacaftor, Deutivacaftor, Vanzacaftor Calcium |
Vertex Pharmaceuticals (canada) Incorporated | Prescription Pharmaceutical New Active Substance (NAS) |
21 Jul 2025 NOC 35709 |
| BLENREP Belantamab Mafodotin 24 clinical trials → |
Glaxosmithkline Inc | Biologic New Active Substance (NAS) |
18 Jul 2025 NOC 35724 |
| LIVMOTY Golimumab 6 clinical trials → |
Janssen Inc | Biologic Labelling Only |
17 Jul 2025 NOC 35686 |
| XIPERE Triamcinolone Acetonide 12 clinical trials → |
Bausch & Lomb Inc | Prescription Pharmaceutical Other |
14 Jul 2025 NOC 35661 |
| PAVBLU Aflibercept 42 clinical trials → |
Amgen Canada Inc | Biologic Other |
8 Jul 2025 NOC 35672 |
| AMIVAS-ARTESUNATE Artesunate 5 clinical trials → |
Amivas Ireland Ltd. | Prescription Pharmaceutical Priority-NAS |
4 Jul 2025 NOC 35628 |
| ISTURISA Osilodrostat Phosphate 2 clinical trials → |
Recordati Rare Diseases Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
3 Jul 2025 NOC 35611 |
| AFLIVU Aflibercept 42 clinical trials → |
Apotex Inc | Biologic Other |
26 Jun 2025 NOC 35600 |
| YESAFILI Aflibercept 42 clinical trials → |
Biosimilar Collaborations Ireland Limited | Biologic Other |
26 Jun 2025 NOC 35598 |
| LYSODREN Mitotane |
Esteve Pharmaceuticals S.a. | Prescription Pharmaceutical Labelling Only |
26 Jun 2025 NOC 35579 |
| LONGAVO Risperidone 8 clinical trials → |
Teva Canada Limited | Prescription Pharmaceutical Other |
18 Jun 2025 NOC 35530 |
| SURFACE CLEANER SANITIZER WIPES, EXELERATE MULTI-SURFACE SANITIZING WIPES Linear Dodecyl Benzene Sulfonic Acid, Lactic Acid |
Ecolab Co | Nonprescription Pharmaceutical Other |
11 Jun 2025 NOC 35494 |
| VANFLYTA Quizartinib Hydrochloride 7 clinical trials → |
Daiichi Sankyo Pharma Canada Limited | Prescription Pharmaceutical New Active Substance (NAS) |
9 Jun 2025 NOC 35483 |
| PIASKY Crovalimab 5 clinical trials → |
Hoffmann-la Roche Limited | Biologic New Active Substance (NAS) |
4 Jun 2025 NOC 35476 |
| PENNSAID Diclofenac Sodium 9 clinical trials → |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
30 May 2025 NOC 35447 |
| TRANDATE Labetalol Hcl 3 clinical trials → |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
23 May 2025 NOC 35427 |
| STERILEX ULTRA-KLEEN SOLUTION Alkyl Dimethyl Ethylbenzyl Ammonium Chloride, Hydrogen Peroxide, Dimethylbenzyl Ammonium Chloride |
Sterilex Llc Dba Sterilex | Nonprescription Pharmaceutical Other |
16 May 2025 NOC 35377 |
| TRIMBOW Beclomethasone Dipropionate, Formoterol Fumarate Dihydrate, Glycopyrronium Bromide |
Chiesi Farmaceutici S.p.a. | Prescription Pharmaceutical Other |
16 May 2025 NOC 35365 |
| PMS-METHADONE Methadone Hydrochloride 5 clinical trials → |
Endo Operations Ltd. | Prescription Pharmaceutical Other |
16 May 2025 NOC 35364 |
| ZEPBOUND KWIKPEN Tirzepatide 58 clinical trials → |
Eli Lilly Canada Inc | Prescription Pharmaceutical Other |
13 May 2025 NOC 35344 |
| MUSE Alprostadil |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
9 May 2025 NOC 35329 |
| AUGTYRO Repotrectinib 7 clinical trials → |
Bristol-myers Squibb Canada | Prescription Pharmaceutical New Active Substance (NAS) |
7 May 2025 NOC 35313 |
| TZIELD Teplizumab 8 clinical trials → |
Sanofi-aventis Canada Inc | Biologic Priority-NAS |
5 May 2025 NOC 35295 |
| LOCACORTEN VIOFORM EARDROPS Clioquinol, Flumethasone Pivalate |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
1 May 2025 NOC 35284 |
| IQIRVO Elafibranor 5 clinical trials → |
Ipsen Biopharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
25 Apr 2025 NOC 35246 |
| RYSTIGGO Rozanolixizumab 6 clinical trials → |
Ucb Canada Inc | Biologic New Active Substance (NAS) |
25 Apr 2025 NOC 35243 |
| LABETALOL HYDROCHLORIDE INJECTION IN 0.72% SODIUM CHLORIDE, LABETALOL HYDROCHLORIDE INJECTION IN 5% DEXTROSE Labetalol Hcl 3 clinical trials → |
Hikma Canada Limited | Prescription Pharmaceutical Other |
24 Apr 2025 NOC 35245 |
| TEPEZZA Teprotumumab 3 clinical trials → |
Amgen Canada Inc | Biologic New Active Substance (NAS) |
17 Apr 2025 NOC 35253 |
| METADOL-D Methadone Hydrochloride 5 clinical trials → |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
15 Apr 2025 NOC 35187 |
| POMBILITI Cipaglucosidase Alfa 3 clinical trials → |
Amicus Therapeutics Canada Inc. | Biologic New Active Substance (NAS) |
14 Apr 2025 NOC 35485 |
| OPFOLDA Miglustat 3 clinical trials → |
Amicus Therapeutics Canada Inc. | Prescription Pharmaceutical Other |
10 Apr 2025 NOC 35159 |
| ELYXYB Celecoxib 23 clinical trials → |
Scilex Pharmaceuticals Inc. | Prescription Pharmaceutical Other |
9 Apr 2025 NOC 35150 |
| NDUVRA Tapinarof 2 clinical trials → |
Dermavant Sciences Gmbh | Prescription Pharmaceutical New Active Substance (NAS) |
4 Apr 2025 NOC 35126 |
| ALTUVIIIO *antihemophilic Factor Viii (recombinant, Bdd), Fc-vwf-xten Fusion Protein |
Sanofi-aventis Canada Inc | Biologic New Active Substance (NAS) |
26 Mar 2025 NOC 35079 |
| FILRA Filgrastim (r-methug-csf) |
Jamp Pharma Corporation | Biologic Other |
24 Mar 2025 NOC 35066 |
| KAVIGALE Sipavibart |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) |
21 Mar 2025 NOC 35099 |
| XFUSOR Ropivacaine Hydrochloride 36 clinical trials → |
Formative Pharma Inc. | Prescription Pharmaceutical Other |
20 Mar 2025 NOC 35051 |
| SEROQUEL XR Quetiapine Fumarate 11 clinical trials → |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
19 Mar 2025 NOC 35043 |
| SEROQUEL Quetiapine Fumarate 11 clinical trials → |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
18 Mar 2025 NOC 35042 |
| METADOL Methadone Hydrochloride 5 clinical trials → |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
18 Mar 2025 NOC 35030 |
| SKYCLARYS Omaveloxolone 5 clinical trials → |
Biogen Canada Inc | Prescription Pharmaceutical Priority-NAS |
13 Mar 2025 NOC 35015 |
| TAPAZOLE Methimazole 3 clinical trials → |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
7 Mar 2025 NOC 34998 |
| ZYNLONTA Loncastuximab Tesirine 6 clinical trials → |
Swedish Orphan Biovitrum Ab (publ) | Biologic New Active Substance (NAS) · with conditions |
7 Mar 2025 NOC 34992 |
| LAZCLUZE Lazertinib Mesylate 15 clinical trials → |
Janssen Inc | Prescription Pharmaceutical New Active Substance (NAS) |
6 Mar 2025 NOC 34959 |
| REBYOTA Fecal Microbiota 3 clinical trials → |
Ferring Inc | Biologic New Active Substance (NAS) |
5 Mar 2025 NOC 34958 |
| SANDOMIGRAN DS Pizotifen Malate |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
5 Mar 2025 NOC 34957 |
| QALSODY Tofersen 3 clinical trials → |
Biogen Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
28 Feb 2025 NOC 34928 |
| SILENOR Doxepin Hcl |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
27 Feb 2025 NOC 34914 |
| TRIDURAL Tramadol Hcl 8 clinical trials → |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
19 Feb 2025 NOC 34871 |
| LOCACORTEN VIOFORM Clioquinol, Flumethasone Pivalate |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
14 Feb 2025 NOC 34849 |
| ITOVEBI Inavolisib 24 clinical trials → |
Hoffmann-la Roche Limited | Prescription Pharmaceutical Priority-NAS |
14 Feb 2025 NOC 34846 |
| KLOXXADO Naloxone Hydrochloride 2 clinical trials → |
Hikma Canada Limited | Prescription Pharmaceutical Other |
12 Feb 2025 NOC 34829 |
| ZYNYZ Retifanlimab 8 clinical trials → |
Incyte Corporation | Biologic New Active Substance (NAS) |
6 Feb 2025 NOC 34808 |
| ZYPREXA, ZYPREXA INTRAMUSCULAR, ZYPREXA ZYDIS Olanzapine, Olanzapine Tartrate |
Cheplapharm Registration Gmbh | Prescription Pharmaceutical Labelling Only |
30 Jan 2025 NOC 34770 |
| VOLTAREN EMULGEL, VOLTAREN EMULGEL ACTIVE, VOLTAREN EMULGEL BACK & MUSCLE PAIN, VOLTAREN EMULGEL JOINT PAIN REGULAR STRENGTH Diclofenac Diethylamine |
Haleon Canada Ulc | Nonprescription Pharmaceutical Labelling Only |
29 Jan 2025 NOC 34772 |
| BAXDELA Delafloxacin Meglumine |
Xediton Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS |
17 Jan 2025 NOC 34700 |
| ARIPIPRAZOLE ORAL SOLUTION Aripiprazole 7 clinical trials → |
Orimed Pharma Inc | Prescription Pharmaceutical Other |
15 Jan 2025 NOC 34691 |
| FABHALTA Iptacopan Hydrochloride 17 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
6 Jan 2025 NOC 34639 |
| FLORINEF Fludrocortisone 21-acetate |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
31 Dec 2024 NOC 34637 |
| OTULFI, OTULFI I.V. Ustekinumab 25 clinical trials → |
Fresenius Kabi Canada Ltd | Biologic Other |
30 Dec 2024 NOC 34641 |
| VABOMERE Meropenem Trihydrate, Vaborbactam |
Xediton Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS |
20 Dec 2024 NOC 34608 |
| RINGZA Ethinyl Estradiol, Segesterone Acetate |
Duchesnay Inc | Prescription Pharmaceutical New Active Substance (NAS) |
18 Dec 2024 NOC 34574 |
| PEXEGRA Pegfilgrastim 18 clinical trials → |
Jamp Pharma Corporation | Biologic Other |
13 Dec 2024 NOC 34568 |
| VYLOY Zolbetuximab 12 clinical trials → |
Astellas Pharma Canada Inc | Biologic New Active Substance (NAS) |
13 Dec 2024 NOC 34557 |
| OMLYCLO Omalizumab 12 clinical trials → |
Celltrion Inc | Biologic Other |
6 Dec 2024 NOC 34519 |
| FLUCELVAX Haemagglutinin-strain A(h1n1), Haemagglutinin-strain A(h3n2), Haemagglutinin-strain A(yam) |
Seqirus Uk Limited | Biologic Other |
3 Dec 2024 NOC 34507 |
| VEOZAH Fezolinetant 2 clinical trials → |
Astellas Pharma Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
2 Dec 2024 NOC 34479 |
| JORNAY PM Methylphenidate Hydrochloride 11 clinical trials → |
Ironshore Pharmaceuticals & Development Inc | Prescription Pharmaceutical Other |
13 Nov 2024 NOC 34375 |
| OJJAARA Momelotinib Dihydrochloride |
Glaxosmithkline Inc | Prescription Pharmaceutical New Active Substance (NAS) |
8 Nov 2024 NOC 34353 |
| MRESVIA *rsv F-protein Mrna, 5'(m7g-5'-ppp-5'-gm), 3'polya |
Moderna Biopharma Canada Corporation | Biologic New Active Substance (NAS) |
6 Nov 2024 NOC 34344 |
| DEXEDRINE, DEXEDRINE SPANSULE Dextroamphetamine Sulfate |
Endo Operations Ltd. | Prescription Pharmaceutical Labelling Only |
6 Nov 2024 NOC 34335 |
| ADVIL FLU Diphenhydramine Hcl, Ibuprofen |
Haleon Canada Ulc | Nonprescription Pharmaceutical Labelling Only |
25 Oct 2024 NOC 34279 |
| ALOG-DOXYLAMINE/PYRIDOXINE Doxylamine Hcl, Pyridoxine Hydrochloride |
Analog Pharma Canada Inc. | Prescription Pharmaceutical Labelling Only |
22 Oct 2024 NOC 34244 |
| DAYBUE Trofinetide |
Acadia Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS |
11 Oct 2024 NOC 34309 |
| OPZELURA Ruxolitinib Phosphate 70 clinical trials → |
Incyte Corporation | Prescription Pharmaceutical Other |
11 Oct 2024 NOC 34186 |
| TYENNE Tocilizumab 71 clinical trials → |
Fresenius Kabi Canada Ltd | Biologic Other |
11 Oct 2024 NOC 34185 |
| CASGEVY Exagamglogene Autotemcel |
Vertex Pharmaceuticals (canada) Incorporated | Biologic Priority-NAS |
23 Sep 2024 NOC 34115 |
| AYVAKYT Avapritinib 8 clinical trials → |
Blueprint Medicines Corporation | Prescription Pharmaceutical New Active Substance (NAS) |
18 Sep 2024 NOC 34039 |
| IMDELLTRA Tarlatamab 25 clinical trials → |
Amgen Canada Inc | Biologic New Active Substance (NAS) · with conditions |
11 Sep 2024 NOC 34010 |
| FRUZAQLA Fruquintinib 45 clinical trials → |
Takeda Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
10 Sep 2024 NOC 33982 |
| MIEBO Perfluorohexyloctane |
Bausch & Lomb Inc | Prescription Pharmaceutical New Active Substance (NAS) |
4 Sep 2024 NOC 33937 |
| WINREVAIR Sotatercept 8 clinical trials → |
Merck Canada Inc | Biologic Priority-NAS |
28 Aug 2024 NOC 33928 |
| VORANIGO Vorasidenib 9 clinical trials → |
Servier Canada Inc | Prescription Pharmaceutical Priority-NAS |
27 Aug 2024 NOC 33876 |
| CLOROTEKAL Chloroprocaine Hydrochloride |
B. Braun Melsungen Ag | Prescription Pharmaceutical Other |
22 Aug 2024 NOC 33855 |
| ACCRUFER Ferric Maltol |
Kye Pharmaceuticals Inc | Prescription Pharmaceutical New Active Substance (NAS) |
21 Aug 2024 NOC 33852 |
| ADHEROZA Trastuzumab 128 clinical trials → |
Accord Healthcare Inc | Biologic Other |
20 Aug 2024 NOC 33930 |
| ARMLUPEG Pegfilgrastim 18 clinical trials → |
Lupin Pharma Canada Limited | Biologic Other |
16 Aug 2024 NOC 33912 |
| PLENVU Ascorbic Acid, Polyethylene Glycol 3350, Potassium Chloride, Sodium Ascorbate, Sodium Chloride, Sodium Sulfate Anhydrous |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Other |
16 Aug 2024 NOC 33824 |
| CABTREO Benzoyl Peroxide, Clindamycin Phosphate, Adapalene |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Other |
14 Aug 2024 NOC 33818 |
| PYZCHIVA, PYZCHIVA IV Ustekinumab 25 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
7 Aug 2024 NOC 33775 |
| PYZCHIVA, PYZCHIVA IV Ustekinumab 25 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
7 Aug 2024 NOC 33774 |
| STEQEYMA, STEQEYMA I.V. Ustekinumab 25 clinical trials → |
Celltrion Inc | Biologic Other |
30 Jul 2024 NOC 33732 |
| FLONASE ALLERGY RELIEF Fluticasone Propionate 2 clinical trials → |
Haleon Canada Ulc | Nonprescription Pharmaceutical Other |
24 Jul 2024 NOC 33695 |
| VOYDEYA Danicopan 4 clinical trials → |
Alexion Pharma Gmbh | Prescription Pharmaceutical New Active Substance (NAS) |
19 Jul 2024 NOC 33685 |
| BORTEZOMIB INJECTION Bortezomib Mannitol Boronic Ester |
Dr Reddys Laboratories Ltd | Prescription Pharmaceutical Other |
19 Jul 2024 NOC 33681 |
| TIBSOVO Ivosidenib 26 clinical trials → |
Servier Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
19 Jul 2024 NOC 33673 |
| SULCRATE, SULCRATE SUSPENSION PLUS Sucralfate 3 clinical trials → |
Abbvie Corporation | Prescription Pharmaceutical Labelling Only |
17 Jul 2024 NOC 33652 |
| CAPVAXIVE Corynebacterium Diphtheriae Crm-197 Protein, Pneumococcal Conjugate Serotype 3, Pneumococcal Polysaccharide Serotype 22f, Pneumococcal Polysaccharide Serotype 6a, Pneumococcal Polysaccharide Serotype 7f, Pneumococcal Polysaccharide Serotype 19a, Pneumococcal Polysaccharide Serotype 9n, Pneumococcal Polysaccharide Serotype 10a |
Merck Canada Inc | Biologic Priority-NAS |
15 Jul 2024 NOC 37230 |
| ATACAND Candesartan Cilexetil |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
11 Jul 2024 NOC 33624 |
| ATACAND PLUS Hydrochlorothiazide, Candesartan Cilexetil |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
11 Jul 2024 NOC 33623 |
| ZILBRYSQ Zilucoplan Sodium 4 clinical trials → |
Ucb Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
11 Jul 2024 NOC 33622 |
| WINDEX MULTI-SURFACE DISINFECTANT SANITIZER CLEANER L-lactic Acid |
S.c. Johnson And Son, Ltd. | Nonprescription Pharmaceutical Other |
5 Jul 2024 NOC 33579 |
| VIBERZI Eluxadoline |
Abbvie Corporation | Prescription Pharmaceutical Labelling Only |
25 Jun 2024 NOC 33521 |
| EBGLYSS Lebrikizumab 10 clinical trials → |
Eli Lilly Canada Inc | Biologic New Active Substance (NAS) |
24 Jun 2024 NOC 33499 |
| IXCHIQ Chikungunya Virus Live-attenuated |
Valneva Austria Gmbh | Biologic New Active Substance (NAS) |
20 Jun 2024 NOC 33480 |
| WAINUA Eplontersen Sodium 4 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
19 Jun 2024 NOC 33471 |
| MEFENAMIC ACID Mefenamic Acid |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
14 Jun 2024 NOC 33450 |
| FAMOTIDINE (ACID CONTROLLER) TABLETS Famotidine 4 clinical trials → |
Teva Canada Limited | Nonprescription Pharmaceutical Other |
14 Jun 2024 NOC 33446 |
| LIBTAYO Cemiplimab 68 clinical trials → |
Regeneron Canada Company | Biologic Labelling Only |
11 Jun 2024 NOC 33433 |
| LEVODOPA-CARBIDOPA Carbidopa, Levodopa |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
30 May 2024 NOC 33353 |
| SEAFORD NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE CREAM Lidocaine Hydrochloride, Nifedipine |
Seaford Pharmaceuticals Inc | Prescription Pharmaceutical Other |
30 May 2024 NOC 33335 |
| CEREZYME Imiglucerase 2 clinical trials → |
Sanofi-aventis Canada Inc | Biologic Labelling Only |
28 May 2024 NOC 33318 |
| MYOZYME Alglucosidase Alfa 2 clinical trials → |
Sanofi-aventis Canada Inc | Biologic Labelling Only |
17 May 2024 NOC 33255 |
| APRETUDE Cabotegravir, Cabotegravir Sodium |
Viiv Healthcare Ulc | Prescription Pharmaceutical Priority |
13 May 2024 NOC 33204 |
| TALVEY Talquetamab 20 clinical trials → |
Janssen Inc | Biologic New Active Substance (NAS) · with conditions |
30 Apr 2024 NOC 33154 |
| NIOPEG Pegfilgrastim 18 clinical trials → |
Nora Pharma Inc | Biologic Other |
17 Apr 2024 NOC 33095 |
| FLUCONAZOLE TABLETS Fluconazole 8 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
17 Apr 2024 NOC 33078 |
| NORDIMET Methotrexate Sodium 97 clinical trials → |
Nordic Group B.v. | Prescription Pharmaceutical Other |
26 Mar 2024 NOC 32956 |
| OKEDI Risperidone 8 clinical trials → |
Laboratorios Farmaceuticos Rovi, S.a. | Prescription Pharmaceutical Other |
21 Mar 2024 NOC 32932 |
| AWIQLI Insulin Icodec 9 clinical trials → |
Novo Nordisk Canada Inc | Biologic New Active Substance (NAS) |
12 Mar 2024 NOC 32994 |
| FERINJECT Ferric Carboxymaltose 9 clinical trials → |
Vifor (international) Inc | Prescription Pharmaceutical New Active Substance (NAS) |
11 Mar 2024 NOC 32857 |
| WYOST Denosumab 23 clinical trials → |
Sandoz Canada Incorporated | Biologic Other |
1 Mar 2024 NOC 32799 |
| XENPOZYME Olipudase Alfa |
Sanofi-aventis Canada Inc | Biologic Priority-NAS |
28 Feb 2024 NOC 32782 |
| JUBBONTI Denosumab 23 clinical trials → |
Sandoz Canada Incorporated | Biologic Other |
16 Feb 2024 NOC 32786 |
| COMBOGESIC IV Acetaminophen, Ibuprofen Sodium Dihydrate |
Biosyent Pharma Inc | Prescription Pharmaceutical Other |
2 Feb 2024 NOC 32633 |
| VELSIPITY Etrasimod L-arginine |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
31 Jan 2024 NOC 32623 |
| TRUQAP Capivasertib 24 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
26 Jan 2024 NOC 32610 |
| MYALEPTA Metreleptin 5 clinical trials → |
Amryt Pharmaceuticals Dac | Biologic Priority-NAS |
17 Jan 2024 NOC 32544 |
| MEROPENEM FOR INJECTION USP AND SODIUM CHLORIDE INJECTION USP Meropenem Trihydrate 13 clinical trials → |
B.braun Medical Inc | Prescription Pharmaceutical Other |
4 Jan 2024 NOC 32457 |
| WEZLANA, WEZLANA I.V. Ustekinumab 25 clinical trials → |
Amgen Canada Inc | Biologic Other |
27 Dec 2023 NOC 32433 |
| BEQVEZ Fidanacogene Elaparvovec |
Pfizer Canada Ulc | Biologic Priority-NAS |
27 Dec 2023 NOC 32406 |
| ABRYSVO Rsv Subgroup A Stabilized Prefusion F Protein, Rsv Subgroup B Stabilized Prefusion F Protein |
Pfizer Canada Ulc | Biologic New Active Substance (NAS) |
21 Dec 2023 NOC 32403 |
| NOYADA Captopril 3 clinical trials → |
Ethypharm Inc | Prescription Pharmaceutical Other |
18 Dec 2023 NOC 32368 |
| UPLIZNA Inebilizumab 12 clinical trials → |
Horizon Therapeutics Ireland Dac | Biologic New Active Substance (NAS) |
15 Dec 2023 NOC 32359 |
| LEVODEXA Dexamethasone, Levofloxacin |
Xediton Pharmaceuticals Inc | Prescription Pharmaceutical Other |
12 Dec 2023 NOC 32338 |
| TEMBEXA Brincidofovir |
Emergent Biodefense Operations Lansing Llc | Prescription Pharmaceutical Other |
11 Dec 2023 NOC 32329 |
| ELREXFIO Elranatamab 31 clinical trials → |
Pfizer Canada Ulc | Biologic New Active Substance (NAS) · with conditions |
6 Dec 2023 NOC 32309 |
| ACAM2000 Vaccinia Virus, Live |
Emergent Product Development Gaithersburg Inc. | Biologic Other |
5 Dec 2023 NOC 32283 |
| NUVAXOVID XBB.1.5 Sars-cov-2 Recombinant Spike Protein (omicron Xbb.1.5) |
Novavax Inc. | Biologic New Active Substance (NAS) |
5 Dec 2023 NOC 32269 |
| NURTEC ODT Rimegepant 15 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
1 Dec 2023 NOC 32254 |
| LITFULO Ritlecitinib 10 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
29 Nov 2023 NOC 32209 |
| SIBBORAN Landiolol Hydrochloride 4 clinical trials → |
Trimedic Therapeutics Inc. | Prescription Pharmaceutical New Active Substance (NAS) |
20 Nov 2023 NOC 32158 |
| ZEVALIN Ibritumomab Tiuxetan |
Auro Pharma Inc | Radiopharmaceutical Labelling Only |
17 Nov 2023 NOC 32284 |
| JAMTEKI Ustekinumab 25 clinical trials → |
Jamp Pharma Corporation | Biologic Other |
15 Nov 2023 NOC 32124 |
| EPIDIOLEX Cannabidiol 16 clinical trials → |
Gw Research Limited | Prescription Pharmaceutical Other |
15 Nov 2023 NOC 32096 |
| PRONEXTICA LIQUID Alpha1-proteinase Inhibitor (human) |
Grifols Therapeutics Llc | Biologic Other |
10 Nov 2023 NOC 32145 |
| RESOTRAN Prucalopride Succinate 2 clinical trials → |
Amdipharm Limited | Prescription Pharmaceutical Labelling Only |
9 Nov 2023 NOC 32053 |
| ASPARLAS Calaspargase Pegol 7 clinical trials → |
Servier Canada Inc | Biologic New Active Substance (NAS) |
8 Nov 2023 NOC 32058 |
| DOPTELET Avatrombopag Maleate 4 clinical trials → |
Swedish Orphan Biovitrum Ab (publ) | Prescription Pharmaceutical New Active Substance (NAS) |
3 Nov 2023 NOC 32030 |
| BYLVAY Odevixibat 2 clinical trials → |
Medison Pharma Canada Inc. | Prescription Pharmaceutical Priority-NAS |
30 Oct 2023 NOC 31966 |
| PANENZA Haemagglutinin-strain A(h1n1) |
Sanofi Pasteur Limited | Biologic Other |
27 Oct 2023 NOC 31953 |
| CLOROXPRO CLOROX ECOCLEAN DISINFECTING CLEANER Lactic Acid |
The Clorox Company Of Canada Ltd | Nonprescription Pharmaceutical Other |
26 Oct 2023 NOC 31941 |
| HEMGENIX Etranacogene Dezaparvovec |
Csl Behring Canada Inc | Biologic Priority-NAS |
23 Oct 2023 NOC 31923 |
| AMVUTTRA Vutrisiran 3 clinical trials → |
Alnylam Netherlands B.v. | Prescription Pharmaceutical New Active Substance (NAS) |
18 Oct 2023 NOC 31880 |
| MYFEMBREE Estradiol, Norethindrone Acetate, Relugolix |
Sumitomo Pharma Switzerland Gmbh | Prescription Pharmaceutical Other |
17 Oct 2023 NOC 31871 |
| EPKINLY Epcoritamab 26 clinical trials → |
Abbvie Corporation | Biologic New Active Substance (NAS) · with conditions |
13 Oct 2023 NOC 31861 |
| RANOPTO Ranibizumab 13 clinical trials → |
Teva Canada Limited | Biologic Other |
11 Oct 2023 NOC 31825 |
| ORGOVYX Relugolix 4 clinical trials → |
Sumitomo Pharma Switzerland Gmbh | Prescription Pharmaceutical New Active Substance (NAS) |
10 Oct 2023 NOC 31810 |
| COMIRNATY OMICRON XBB.1.5 Raxtozinameran |
Biontech Manufacturing Gmbh | Biologic New Active Substance (NAS) |
28 Sep 2023 NOC 31809 |
| EVKEEZA Evinacumab |
Ultragenyx Pharmaceutical Inc | Biologic Priority-NAS |
22 Sep 2023 NOC 31701 |
| MYFEMBREE Estradiol, Norethindrone Acetate, Relugolix |
Sumitomo Pharma Switzerland Gmbh | Prescription Pharmaceutical New Active Substance (NAS) |
22 Sep 2023 NOC 31691 |
| QUILLIVANT ER CHEWABLE TABLETS, QUILLIVANT ER ORAL SUSPENSION Methylphenidate Hydrochloride 11 clinical trials → |
Kye Pharmaceuticals Inc | Prescription Pharmaceutical Other |
21 Sep 2023 NOC 31681 |
| VYVGART Efgartigimod Alfa |
Argenx Bv | Biologic New Active Substance (NAS) |
19 Sep 2023 NOC 31686 |
| OPDUALAG Nivolumab, Relatlimab |
Bristol-myers Squibb Canada | Biologic New Active Substance (NAS) |
13 Sep 2023 NOC 31617 |
| SPIKEVAX XBB.1.5 Andusomeran |
Moderna Biopharma Canada Corporation | Biologic New Active Substance (NAS) |
12 Sep 2023 NOC 31589 |
| NITROGLYCERIN INJECTION USP Nitroglycerin 6 clinical trials → |
Mont-pharma Inc | Nonprescription Pharmaceutical Other |
8 Sep 2023 NOC 31580 |
| AA-IPRAVENT Ipratropium Bromide Monohydrate |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
5 Sep 2023 NOC 31544 |
| IMJUDO Tremelimumab 47 clinical trials → |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) |
31 Aug 2023 NOC 31534 |
| AREXVY Respiratory Syncytial Virus Prefusion F Protein (rsvpref3) |
Glaxosmithkline Inc | Biologic New Active Substance (NAS) |
4 Aug 2023 NOC 31366 |
| AXBERI, AXBERI HP Enoxaparin Sodium 22 clinical trials → |
Baxter Corporation | Biologic Other |
27 Jul 2023 NOC 31320 |
| NAPROXEN LIQUID GELS Naproxen 2 clinical trials → |
Juno Otc Inc | Nonprescription Pharmaceutical Other |
27 Jul 2023 NOC 31311 |
| SOGROYA Somapacitan 7 clinical trials → |
Novo Nordisk Canada Inc | Biologic New Active Substance (NAS) |
26 Jul 2023 NOC 31315 |
| TECVAYLI Teclistamab 34 clinical trials → |
Janssen Inc | Biologic New Active Substance (NAS) · with conditions |
26 Jul 2023 NOC 31304 |
| ALHEMO Concizumab 5 clinical trials → |
Novo Nordisk Canada Inc | Biologic Other |
26 Jul 2023 NOC 31301 |
| LIVMARLI Maralixibat Chloride 4 clinical trials → |
Mirum Pharmaceuticals, Inc. | Prescription Pharmaceutical Priority-NAS |
21 Jul 2023 NOC 31282 |
| OMVOH Mirikizumab 18 clinical trials → |
Eli Lilly Canada Inc | Biologic New Active Substance (NAS) |
20 Jul 2023 NOC 31279 |
| PROCAN SR Procainamide Hcl |
Searchlight Pharma Inc | Prescription Pharmaceutical Labelling Only |
29 Jun 2023 NOC 31118 |
| ABSORICA LD Isotretinoin 8 clinical trials → |
Sun Pharmaceutical Industries Limited | Prescription Pharmaceutical Other |
22 Jun 2023 NOC 31038 |
| ONDEXXYA Andexanet Alfa |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) · with conditions |
16 Jun 2023 NOC 30999 |
| WINLEVI Clascoterone |
Sun Pharmaceutical Industries Limited | Prescription Pharmaceutical New Active Substance (NAS) |
15 Jun 2023 NOC 31005 |
| AKEEGA Abiraterone Acetate, Niraparib |
Janssen Inc | Prescription Pharmaceutical Other · with conditions |
12 Jun 2023 NOC 30973 |
| XCOPRI Cenobamate 4 clinical trials → |
Endo Ventures Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
12 Jun 2023 NOC 30970 |
| XYWAV Sodium Oxybate, Calcium Oxybate, Magnesium Oxybate, Potassium Oxybate |
Jazz Pharmaceuticals Ireland Limited | Prescription Pharmaceutical Other |
25 May 2023 NOC 30821 |
| NAVANE Thiothixene |
Searchlight Pharma Inc | Prescription Pharmaceutical Labelling Only |
24 May 2023 NOC 30813 |
| VAXCHORA Vibrio Cholerae, Strain Cvd 103-hgr, Live |
Emergent Travel Health Inc. | Biologic Other |
18 May 2023 NOC 30782 |
| ONAKTA Tirbanibulin 2 clinical trials → |
Avir Pharma Inc | Prescription Pharmaceutical New Active Substance (NAS) |
12 May 2023 NOC 30717 |
| ZOFRAN ODT Ondansetron 17 clinical trials → |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
11 May 2023 NOC 30732 |
| IMCIVREE Setmelanotide Acetate 4 clinical trials → |
Rhythm Pharmaceuticals, Inc | Prescription Pharmaceutical Priority-NAS |
5 May 2023 NOC 30643 |
| VYALEV Foscarbidopa, Foslevodopa |
Abbvie Corporation | Prescription Pharmaceutical Other |
3 May 2023 NOC 30636 |
| QUVIVIQ Daridorexant Hydrochloride 8 clinical trials → |
Idorsia Pharmaceuticals Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
28 Apr 2023 NOC 30614 |
| ZORYVE Roflumilast 8 clinical trials → |
Arcutis Biotherapeutics, Inc | Prescription Pharmaceutical Other |
28 Apr 2023 NOC 30608 |
| VERQUVO Vericiguat 11 clinical trials → |
Bayer Inc | Prescription Pharmaceutical New Active Substance (NAS) |
28 Apr 2023 NOC 30582 |
| BEYFORTUS Nirsevimab 8 clinical trials → |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) |
19 Apr 2023 NOC 30540 |
| FINLIUS, FINLIUS I.V. Ustekinumab 25 clinical trials → |
Janssen Inc | Biologic Labelling Only |
18 Apr 2023 NOC 30543 |
| LOCAMETZ Gallium (68ga) Gozetotide |
Advanced Accelerator Applications Usa, Inc. | Radiopharmaceutical New Active Substance (NAS) |
5 Apr 2023 NOC 30480 |
| COLUMVI Glofitamab 46 clinical trials → |
Hoffmann-la Roche Limited | Biologic New Active Substance (NAS) · with conditions |
24 Mar 2023 NOC 30384 |
| SPEVIGO Spesolimab 3 clinical trials → |
Boehringer Ingelheim (canada) Ltd Ltee | Biologic Priority-NAS |
22 Mar 2023 NOC 30360 |
| MICRO+ TE PEDIATRIC Cupric Sulfate, Manganese Sulfate, Selenious Acid, Sodium Iodide, Zinc Sulfate |
Sandoz Canada Incorporated | Prescription Pharmaceutical Other |
15 Mar 2023 NOC 30328 |
| ALHEMO Concizumab 5 clinical trials → |
Novo Nordisk Canada Inc | Biologic Priority-NAS |
10 Mar 2023 NOC 30312 |
| CALQUENCE Acalabrutinib 48 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical Other |
27 Feb 2023 NOC 30214 |
| ACETAMINOPHEN INJECTION Acetaminophen 36 clinical trials → |
B. Braun Melsungen Ag | Prescription Pharmaceutical Other |
24 Feb 2023 NOC 30213 |
| FLUOXETINE Fluoxetine 10 clinical trials → |
Sivem Pharmaceuticals Ulc | Prescription Pharmaceutical Other |
15 Feb 2023 NOC 30132 |
| CARVYKTI Ciltacabtagene Autoleucel |
Janssen Inc | Biologic New Active Substance (NAS) · with conditions |
9 Feb 2023 NOC 30099 |
| PRZ-METFORMIN Metformin Hydrochloride 105 clinical trials → |
Pharmaris Canada Inc | Prescription Pharmaceutical Other |
24 Jan 2023 NOC 29962 |
| KENGREXAL Cangrelor Tetrasodium |
Chiesi Farmaceutici S.p.a. | Prescription Pharmaceutical New Active Substance (NAS) |
20 Jan 2023 NOC 29960 |
| RUZURGI Amifampridine |
Medunik Canada | Prescription Pharmaceutical Priority-NAS |
10 Jan 2023 NOC 24015 |
| VEGZELMA Bevacizumab 400 clinical trials → |
Celltrion Healthcare Co Ltd | Biologic Other |
3 Jan 2023 NOC 29820 |
| QULIPTA Atogepant 8 clinical trials → |
Abbvie Corporation | Prescription Pharmaceutical New Active Substance (NAS) |
22 Dec 2022 NOC 29754 |
| DESIPRAMINE Desipramine Hcl |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
16 Dec 2022 NOC 29722 |
| MIFISO Mifepristone, Misoprostol |
Linepharma International Limited | Prescription Pharmaceutical Other |
16 Dec 2022 NOC 29717 |
| ZIMED PF Bimatoprost |
Aequus Pharmaceuticals Inc | Prescription Pharmaceutical Other |
14 Dec 2022 NOC 29704 |
| EMPAVELI Pegcetacoplan 7 clinical trials → |
Swedish Orphan Biovitrum Ab (publ) | Prescription Pharmaceutical Priority-NAS |
8 Dec 2022 NOC 29644 |
| PREHEVBRIO Hepatitis B Surface Antigen (recombinant) |
Vbi Vaccines Inc. | Biologic New Active Substance (NAS) |
6 Dec 2022 NOC 29632 |
| GERMSTOPSQ Benzalkonium Chloride, Alcohol Anhydrous, Alkyl Dimethyl Ethylbenzyl Ammonium Chloride, Didecyl Dimethyl Ammonium Chloride, Cetrimonium Bromide |
Envision Sq Inc. | Nonprescription Pharmaceutical Other |
29 Nov 2022 NOC 29578 |
| SOTYKTU Deucravacitinib 28 clinical trials → |
Bristol-myers Squibb Canada | Prescription Pharmaceutical New Active Substance (NAS) |
24 Nov 2022 NOC 29540 |
| MOUNJARO Tirzepatide 58 clinical trials → |
Eli Lilly Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
24 Nov 2022 NOC 29535 |
| UBRELVY Ubrogepant 4 clinical trials → |
Abbvie Corporation | Prescription Pharmaceutical New Active Substance (NAS) |
10 Nov 2022 NOC 29425 |
| ERVEBO Ebola Zaire Vaccine (rvsv [delta] G-zebov-gp, Live) |
Merck Canada Inc | Biologic New Active Substance (NAS) |
9 Nov 2022 NOC 29418 |
| CAMZYOS Mavacamten 15 clinical trials → |
Bristol-myers Squibb Canada | Prescription Pharmaceutical New Active Substance (NAS) |
8 Nov 2022 NOC 29414 |
| SPIKEVAX BIVALENT (ORIGINAL/OMICRON BA.4/5) Elasomeran, Davesomeran |
Modernatx, Inc. | Biologic New Active Substance (NAS) |
3 Nov 2022 NOC 29369 |
| SUNLENCA Lenacapavir Sodium 17 clinical trials → |
Gilead Sciences Canada Inc | Prescription Pharmaceutical Priority-NAS |
2 Nov 2022 NOC 29368 |
| ELONOX, ELONOX HP Enoxaparin Sodium 22 clinical trials → |
Fresenius Kabi Canada Ltd | Biologic Other |
26 Oct 2022 NOC 29299 |
| REZUROCK Belumosudil Mesylate 6 clinical trials → |
Sanofi-aventis Canada Inc | Prescription Pharmaceutical Labelling Only |
21 Oct 2022 NOC 29313 |
| COMIRNATY ORIGINAL/OMICRON BA.1 Tozinameran, Riltozinameran |
Biontech Manufacturing Gmbh | Biologic New Active Substance (NAS) |
21 Oct 2022 NOC 29274 |
| HEPAGAM B Hepatitis B Immunoglobulin (human) |
Ki Biopharma Llc | Biologic Labelling Only · with conditions |
19 Oct 2022 NOC 29233 |
| KERENDIA Finerenone 34 clinical trials → |
Bayer Inc | Prescription Pharmaceutical New Active Substance (NAS) |
14 Oct 2022 NOC 29218 |
| ILLUCCIX Gallium (68ga) Gozetotide |
Telix Pharmaceuticals (us) Inc | Radiopharmaceutical New Active Substance (NAS) |
13 Oct 2022 NOC 29209 |
| AA-METOPROLOL SR Metoprolol Tartrate 4 clinical trials → |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
13 Oct 2022 NOC 29189 |
| AURO-LEVOCARB Carbidopa, Levodopa |
Auro Pharma Inc | Prescription Pharmaceutical Other |
11 Oct 2022 NOC 29168 |
| COMIRNATY ORIGINAL & OMICRON BA.4/BA.5 Tozinameran, Famtozinameran |
Biontech Manufacturing Gmbh | Biologic New Active Substance (NAS) |
7 Oct 2022 NOC 29148 |
| LEO PHARMA - TACROLIMUS Tacrolimus 40 clinical trials → |
Leo Pharma Gen, A Division Of Leo Pharma Inc. | Prescription Pharmaceutical Labelling Only |
29 Sep 2022 NOC 29097 |
| RYALTRIS Olopatadine Hcl, Mometasone Furoate Monohydrate |
Glenmark Specialty Sa | Prescription Pharmaceutical Other |
21 Sep 2022 NOC 29025 |
| LIVTENCITY Maribavir 7 clinical trials → |
Takeda Canada Inc | Prescription Pharmaceutical Priority-NAS |
15 Sep 2022 NOC 28992 |
| METHOFILL SELF-DOSE INJECTOR Methotrexate Sodium 97 clinical trials → |
Accord Healthcare Inc | Prescription Pharmaceutical Other |
15 Sep 2022 NOC 28960 |
| SUSVIMO Ranibizumab 13 clinical trials → |
Hoffmann-la Roche Limited | Biologic Other |
14 Sep 2022 NOC 28961 |
| EYEZIRGAN Ganciclovir 3 clinical trials → |
Laboratoires Thea | Prescription Pharmaceutical Other |
8 Sep 2022 NOC 28910 |
| RYLAZE Crisantaspase, Recombinant |
Jazz Pharmaceuticals Ireland Limited | Biologic Other |
2 Sep 2022 NOC 28897 |
| SPIKEVAX BIVALENT Elasomeran, Imelasomeran |
Modernatx, Inc. | Biologic New Active Substance (NAS) |
1 Sep 2022 NOC 28861 |
| RYMTI Etanercept 11 clinical trials → |
Lupin Pharma Canada Limited | Biologic Other |
31 Aug 2022 NOC 28898 |
| KOSELUGO Selumetinib Sulfate 18 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
31 Aug 2022 NOC 28862 |
| PLUVICTO Lutetium (177lu) Vipivotide Tetraxetan |
Advanced Accelerator Applications Usa, Inc. | Radiopharmaceutical Priority-NAS |
25 Aug 2022 NOC 28832 |
| CONRAY 60 Iothalamate Meglumine |
Liebel-flarsheim Company Llc | Prescription Pharmaceutical Labelling Only |
24 Aug 2022 NOC 28833 |
| KORSUVA Difelikefalin |
Vifor Fresenius Medical Care Renal Pharma Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
16 Aug 2022 NOC 28760 |
| MYXREDLIN Human Insulin (recombinant) |
Baxter Corporation | Biologic Other |
3 Aug 2022 NOC 28702 |
| S&S SANITIZER Linear Dodecyl Benzene Sulfonic Acid, L-lactic Acid |
Ecolab Co | Nonprescription Pharmaceutical Other |
2 Aug 2022 NOC 28681 |
| EXELERATE CSD 15 Linear Dodecyl Benzene Sulfonic Acid, L-lactic Acid |
Ecolab Co | Nonprescription Pharmaceutical Other |
2 Aug 2022 NOC 28680 |
| CLEANING SANITIZER AND DISINFECTANT RTU Linear Dodecyl Benzene Sulfonic Acid, L-lactic Acid |
Ecolab Co | Nonprescription Pharmaceutical Other |
2 Aug 2022 NOC 28679 |
| TEZSPIRE Tezepelumab 14 clinical trials → |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) |
28 Jul 2022 NOC 28666 |
| WELIREG Belzutifan 20 clinical trials → |
Merck Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
11 Jul 2022 NOC 28568 |
| CIBINQO Abrocitinib 11 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
29 Jun 2022 NOC 28491 |
| SCEMBLIX Asciminib Hydrochloride 7 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
22 Jun 2022 NOC 28446 |
| LETYBO Letibotulinumtoxina |
Croma Aesthetics Canada, Ltd. | Biologic Other |
14 Jun 2022 NOC 28398 |
| ALBRIOZA Sodium Phenylbutyrate, Ursodoxicoltaurine |
Amylyx Pharmaceuticals Inc. | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
10 Jun 2022 NOC 28373 |
| KIMMTRAK Tebentafusp 4 clinical trials → |
Immunocore Ireland Limited | Biologic Priority-NAS |
7 Jun 2022 NOC 28332 |
| APO-BUSPIRONE Buspirone Hcl 2 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
3 Jun 2022 NOC 28319 |
| POTELIGEO Mogamulizumab 3 clinical trials → |
Kyowa Kirin, Inc. | Biologic New Active Substance (NAS) |
2 Jun 2022 NOC 28317 |
| ORLADEYO Berotralstat Hydrochloride 2 clinical trials → |
Biocryst Pharmaceuticals Inc | Prescription Pharmaceutical New Active Substance (NAS) |
2 Jun 2022 NOC 28315 |
| XPOVIO Selinexor 47 clinical trials → |
Forus Therapeutics Inc | Prescription Pharmaceutical New Active Substance (NAS) |
31 May 2022 NOC 28287 |
| VABYSMO Faricimab 16 clinical trials → |
Hoffmann-la Roche Limited | Biologic New Active Substance (NAS) |
27 May 2022 NOC 28281 |
| TABRECTA Capmatinib Hydrochloride 5 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
26 May 2022 NOC 30374 |
| LUMIFY Brimonidine Tartrate |
Bausch & Lomb Inc | Nonprescription Pharmaceutical Other |
19 May 2022 NOC 28208 |
| PREVNAR 20 Pneumococcal Polysaccharide Serotype 4, Pneumococcal Polysaccharide Serotype 6b, Pneumococcal Polysaccharide Serotype 14, Pneumococcal Polysaccharide Serotype 19f, Pneumococcal Polysaccharide Serotype 23f, Corynebacterium Diphtheriae Crm-197 Protein, Pneumococcal Polysaccharide Serotype 9v, Pneumococcal Polysaccharide Serotype 18c |
Pfizer Canada Ulc | Biologic New Active Substance (NAS) |
9 May 2022 NOC 28117 |
| BREYANZI Lisocabtagene Maraleucel 9 clinical trials → |
Celgene Inc | Biologic New Active Substance (NAS) |
6 May 2022 NOC 28100 |
| ESAMUZE Bendamustine Hydrochloride 51 clinical trials → |
Dr Reddys Laboratories Ltd | Prescription Pharmaceutical Other |
4 May 2022 NOC 28082 |
| RIVOTRIL Clonazepam 2 clinical trials → |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Other |
29 Apr 2022 NOC 28047 |
| VRAYLAR Cariprazine Hydrochloride 5 clinical trials → |
Allergan Inc | Prescription Pharmaceutical New Active Substance (NAS) |
22 Apr 2022 NOC 28008 |
| TAVNEOS Avacopan 4 clinical trials → |
Vifor Fresenius Medical Care Renal Pharma Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
14 Apr 2022 NOC 27984 |
| EVUSHELD Tixagevimab, Cilgavimab |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) |
14 Apr 2022 NOC 27978 |
| SEMGLEE Insulin Glargine 2 clinical trials → |
Bgp Pharma Ulc | Biologic Other |
8 Apr 2022 NOC 27950 |
| RYBREVANT Amivantamab 30 clinical trials → |
Janssen Inc | Biologic New Active Substance (NAS) · with conditions |
30 Mar 2022 NOC 27857 |
| PALYNZIQ Pegvaliase 5 clinical trials → |
Biomarin International Limited | Biologic New Active Substance (NAS) |
30 Mar 2022 NOC 27856 |
| RHOLISTIQ Belumosudil Mesylate 6 clinical trials → |
Kadmon Pharmaceuticals Llc | Prescription Pharmaceutical Priority-NAS |
23 Mar 2022 NOC 27798 |
| ZYNRELEF Bupivacaine, Meloxicam |
Heron Therapeutics, Inc. | Prescription Pharmaceutical Other |
16 Mar 2022 NOC 27777 |
| BYOOVIZ Ranibizumab 13 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
8 Mar 2022 NOC 27735 |
| OXLUMO Lumasiran Sodium |
Alnylam Netherlands B.v. | Prescription Pharmaceutical Priority-NAS |
7 Mar 2022 NOC 27720 |
| COVIFENZ Virus-like Particles (vlp) Of Sars-cov-2 Spike Protein |
Medicago Inc | Biologic New Active Substance (NAS) |
24 Feb 2022 NOC 27704 |
| NETVISION Gallium 68 Ga Oxodotreotide |
Canadian Molecular Imaging Probe Consortium (canprobe) | Radiopharmaceutical New Active Substance (NAS) |
24 Feb 2022 NOC 27664 |
| NUVAXOVID Sars-cov-2 Recombinant Spike Protein |
Novavax Inc. | Biologic New Active Substance (NAS) |
17 Feb 2022 NOC 27627 |
| DIACETYLMORPHINE HYDROCHLORIDE Diamorphine Hcl |
Pharmascience Inc | Prescription Pharmaceutical Other |
16 Feb 2022 NOC 27616 |
| BIMZELX Bimekizumab 9 clinical trials → |
Ucb Canada Inc | Biologic New Active Substance (NAS) |
14 Feb 2022 NOC 27593 |
| ONE-ALPHA Alfacalcidol |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
29 Jan 2022 NOC 27492 |
| GLICLAZIDE MR Gliclazide |
Sanis Health Inc | Prescription Pharmaceutical Labelling Only |
28 Jan 2022 NOC 27518 |
| ONTRUZANT Trastuzumab 128 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
28 Jan 2022 NOC 27499 |
| SOHONOS Palovarotene |
Ipsen Biopharmaceuticals Canada Inc | Prescription Pharmaceutical Priority-NAS |
21 Jan 2022 NOC 27451 |
| MEZERA Mesalazine 4 clinical trials → |
Avir Pharma Inc | Prescription Pharmaceutical Other |
18 Jan 2022 NOC 27415 |
| PAXLOVID Ritonavir, Nirmatrelvir |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
17 Jan 2022 NOC 27404 |
| HYQVIA Immunoglobulin (human), Hyaluronidase (human Recombinant) |
Takeda Canada Inc | Biologic New Active Substance (NAS) |
14 Jan 2022 NOC 27412 |
| BENVYON Bendamustine Hydrochloride 51 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical Other |
14 Jan 2022 NOC 27402 |
| SIMLANDI Adalimumab 35 clinical trials → |
Jamp Pharma Corporation | Biologic Other |
5 Jan 2022 NOC 27339 |
| YUFLYMA Adalimumab 35 clinical trials → |
Celltrion Healthcare Co Ltd | Biologic Other |
24 Dec 2021 NOC 27311 |
| TICLOPIDINE Ticlopidine Hcl |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
23 Dec 2021 NOC 27291 |
| JEMPERLI Dostarlimab 42 clinical trials → |
Glaxosmithkline Inc | Biologic New Active Substance (NAS) · with conditions |
23 Dec 2021 NOC 27285 |
| SMARTPOWER SINK & SURFACE CLEANER SANITIZER, SURFACE CLEANER SANITIZER RTU Linear Dodecyl Benzene Sulfonic Acid, L-lactic Acid |
Ecolab Co | Nonprescription Pharmaceutical Other |
22 Dec 2021 NOC 27284 |
| IXIFI Infliximab 39 clinical trials → |
Pfizer Canada Ulc | Biologic Other |
21 Dec 2021 NOC 27276 |
| DEXLANSOPRAZOLE Dexlansoprazole |
Takeda Canada Inc | Prescription Pharmaceutical Labelling Only |
17 Dec 2021 NOC 27264 |
| PERINDOPRIL ERBUMINE/INDAPAMIDE, PERINDOPRIL ERBUMINE/INDAPAMIDE HD, PERINDOPRIL ERBUMINE/INDAPAMIDE LD Perindopril Erbumine, Indapamide |
Pro Doc Limitee | Prescription Pharmaceutical Labelling Only |
7 Dec 2021 NOC 27185 |
| SOTALOL Sotalol Hydrochloride |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
7 Dec 2021 NOC 27183 |
| AYBINTIO Bevacizumab 400 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
30 Nov 2021 NOC 27143 |
| SAPHNELO Anifrolumab 12 clinical trials → |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) |
30 Nov 2021 NOC 27137 |
| SLYND Drospirenone 5 clinical trials → |
Duchesnay Inc | Prescription Pharmaceutical Other |
30 Nov 2021 NOC 27131 |
| TPOXX Tecovirimat Monohydrate 2 clinical trials → |
Siga Technologies, Inc. | Prescription Pharmaceutical New Active Substance (NAS) |
29 Nov 2021 NOC 27127 |
| SEPTRA PEDIATRIC SUSPENSION Sulfamethoxazole, Trimethoprim |
Aspen Pharmacare Canada Inc. | Prescription Pharmaceutical Labelling Only |
29 Nov 2021 NOC 27119 |
| WEGOVY Semaglutide 110 clinical trials → |
Novo Nordisk Canada Inc | Biologic Other |
23 Nov 2021 NOC 27091 |
| JANSSEN COVID-19 VACCINE Ad26.cov2.s [recombinant] |
Janssen Inc | Biologic New Active Substance (NAS) |
23 Nov 2021 NOC 27082 |
| BELKYRA Deoxycholic Acid |
Allergan Inc | Prescription Pharmaceutical Labelling Only |
22 Nov 2021 NOC 27071 |
| AYBINTIO Bevacizumab 400 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
20 Nov 2021 NOC 27146 |
| VAXZEVRIA Chadox1-s [recombinant] |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) |
19 Nov 2021 NOC 27078 |
| CAMCEVI Leuprolide Mesylate 10 clinical trials → |
Accord Healthcare Inc | Prescription Pharmaceutical Other |
16 Nov 2021 NOC 27046 |
| VAXNEUVANCE Pneumococcal Polysaccharide Serotype 4, Pneumococcal Polysaccharide Serotype 6b, Pneumococcal Polysaccharide Serotype 14, Pneumococcal Polysaccharide Serotype 19f, Pneumococcal Polysaccharide Serotype 23f, Corynebacterium Diphtheriae Crm-197 Protein, Pneumococcal Polysaccharide Serotype 9v, Pneumococcal Polysaccharide Serotype 18c |
Merck Canada Inc | Biologic New Active Substance (NAS) |
16 Nov 2021 NOC 27045 |
| GLASSIA Alpha1-proteinase Inhibitor (human) |
Takeda Canada Inc | Biologic Other |
12 Nov 2021 NOC 27030 |
| NEXVIAZYME Avalglucosidase Alfa 7 clinical trials → |
Sanofi-aventis Canada Inc | Biologic New Active Substance (NAS) |
12 Nov 2021 NOC 27027 |
| ABEVMY Bevacizumab 400 clinical trials → |
Bgp Pharma Ulc | Biologic Other |
5 Nov 2021 NOC 26998 |
| GENTAMICIN INJECTION USP Gentamicin Sulfate 6 clinical trials → |
Telip, Llc, A Subsidiary Of Teligent, Inc. | Prescription Pharmaceutical Labelling Only |
4 Nov 2021 NOC 26978 |
| PADCEV Enfortumab Vedotin 34 clinical trials → |
Seagen Inc. | Biologic Priority-NAS |
29 Oct 2021 NOC 26950 |
| NGENLA Somatrogon 3 clinical trials → |
Pfizer Canada Ulc | Biologic New Active Substance (NAS) |
26 Oct 2021 NOC 26936 |
| CEPHALEXIN Cephalexin Monohydrate |
Sanis Health Inc | Prescription Pharmaceutical Labelling Only |
18 Oct 2021 NOC 26862 |
| OPSYNVI Tadalafil, Macitentan |
Janssen Inc | Prescription Pharmaceutical Other |
14 Oct 2021 NOC 26835 |
| ADTRALZA Tralokinumab 2 clinical trials → |
Leo Pharma Inc | Biologic New Active Substance (NAS) |
13 Oct 2021 NOC 26843 |
| KIRSTY Insulin Aspart 3 clinical trials → |
Bgp Pharma Ulc | Biologic Other |
12 Oct 2021 NOC 26827 |
| NYPOZI Filgrastim (r-methug-csf) |
Tanvex Biopharma Usa, Inc | Biologic Other |
8 Oct 2021 NOC 26856 |
| RUKOBIA Fostemsavir Tromethamine |
Viiv Healthcare Ulc | Prescription Pharmaceutical Priority-NAS |
1 Oct 2021 NOC 26753 |
| ZEPZELCA Lurbinectedin 17 clinical trials → |
Jazz Pharmaceuticals Ireland Limited | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
29 Sep 2021 NOC 26751 |
| TRUSELTIQ Infigratinib Phosphate 3 clinical trials → |
Qed Therapeutics, Inc. | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
27 Sep 2021 NOC 26725 |
| TRODELVY Sacituzumab Govitecan 60 clinical trials → |
Gilead Sciences Canada Inc | Biologic Priority-NAS |
24 Sep 2021 NOC 26736 |
| BAMBEVI Bevacizumab 400 clinical trials → |
Apotex Inc | Biologic Other |
23 Sep 2021 NOC 27105 |
| PEMAZYRE Pemigatinib 3 clinical trials → |
Incyte Corporation | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
17 Sep 2021 NOC 26673 |
| COMIRNATY Tozinameran |
Biontech Manufacturing Gmbh | Biologic New Active Substance (NAS) |
16 Sep 2021 NOC 26914 |
| SPIKEVAX Elasomeran |
Modernatx, Inc. | Biologic New Active Substance (NAS) |
16 Sep 2021 NOC 26907 |
| TENOXICAM Tenoxicam 2 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
16 Sep 2021 NOC 26660 |
| LYUMJEV Insulin Lispro 2 clinical trials → |
Eli Lilly Canada Inc | Biologic Other |
14 Sep 2021 NOC 26649 |
| LUMAKRAS Sotorasib 14 clinical trials → |
Amgen Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
10 Sep 2021 NOC 26627 |
| DESIPRAMINE Desipramine Hcl |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
8 Sep 2021 NOC 26652 |
| ADVIL PLUS ACETAMINOPHEN Acetaminophen, Ibuprofen |
Glaxosmithkline Consumer Healthcare Ulc | Nonprescription Pharmaceutical Other |
23 Aug 2021 NOC 26495 |
| MYINFLA Colchicine 39 clinical trials → |
Pendopharm Division Of Pharmascience Inc | Prescription Pharmaceutical Priority |
23 Aug 2021 NOC 26491 |
| MINJUVI Tafasitamab 13 clinical trials → |
Incyte Corporation | Biologic New Active Substance (NAS) · with conditions |
19 Aug 2021 NOC 26490 |
| NIDAGEL Metronidazole 16 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
18 Aug 2021 NOC 26459 |
| DIASTAT Diazepam |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
18 Aug 2021 NOC 26456 |
| VABLYS Dequalinium Chloride |
Duchesnay Inc | Prescription Pharmaceutical Other |
28 Jul 2021 NOC 26351 |
| LEQVIO Inclisiran Sodium 11 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
26 Jul 2021 NOC 26327 |
| DYSPORT AWSTHETIC, DYSPORT THERAPEUTIC Abobotulinumtoxina |
Ipsen Biopharmaceuticals Canada Inc | Biologic Labelling Only |
23 Jul 2021 NOC 26329 |
| BRUKINSA Zanubrutinib 62 clinical trials → |
Beigene Switzerland Gmbh | Prescription Pharmaceutical Other |
22 Jul 2021 NOC 26311 |
| BROMAZEPAM Bromazepam |
Apotex Inc | Prescription Pharmaceutical Other |
19 Jul 2021 NOC 26284 |
| OSPHENA Ospemifene |
Duchesnay Inc | Prescription Pharmaceutical New Active Substance (NAS) |
16 Jul 2021 NOC 26271 |
| BREZTRI AEROSPHERE Budesonide, Formoterol Fumarate Dihydrate, Glycopyrronium Bromide |
Astrazeneca Canada Inc | Prescription Pharmaceutical Other |
15 Jul 2021 NOC 26289 |
| EDARBYCLOR Chlorthalidone, Azilsartan Medoxomil Potassium |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
13 Jul 2021 NOC 26249 |
| EDARBI Azilsartan Medoxomil Potassium |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
13 Jul 2021 NOC 26248 |
| VYNDAMAX Tafamidis |
Pfizer Canada Ulc | Prescription Pharmaceutical Other |
9 Jul 2021 NOC 26239 |
| ARAZLO Tazarotene |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Other |
8 Jul 2021 NOC 26223 |
| AGRYLIN Anagrelide Hydrochloride 2 clinical trials → |
Takeda Canada Inc | Prescription Pharmaceutical Labelling Only |
7 Jul 2021 NOC 26225 |
| GAVRETO Pralsetinib 6 clinical trials → |
Hoffmann-la Roche Limited | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
30 Jun 2021 NOC 26190 |
| TRECONDYV Treosulfan 4 clinical trials → |
Medexus Inc | Prescription Pharmaceutical Priority |
25 Jun 2021 NOC 26154 |
| RALIVIA Tramadol Hcl 8 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Other |
25 Jun 2021 NOC 26146 |
| MANERIX Moclobemide |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
24 Jun 2021 NOC 26130 |
| TRIKAFTA Ivacaftor, Tezacaftor, Elexacaftor |
Vertex Pharmaceuticals (canada) Incorporated | Prescription Pharmaceutical Priority-NAS |
18 Jun 2021 NOC 26093 |
| RETEVMO Selpercatinib 13 clinical trials → |
Loxo Oncology Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
15 Jun 2021 NOC 26077 |
| WELLBUTRIN XL Bupropion Hydrochloride 7 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
11 Jun 2021 NOC 26062 |
| TRYPTAN L-tryptophan |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
11 Jun 2021 NOC 26061 |
| EFUDEX Fluorouracil 94 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
10 Jun 2021 NOC 26025 |
| TECARTUS Brexucabtagene Autoleucel |
Gilead Sciences Canada Inc | Biologic Priority-NAS |
8 Jun 2021 NOC 26027 |
| LEDAGA Chlormethine |
Recordati Rare Diseases Canada Inc | Prescription Pharmaceutical Other |
8 Jun 2021 NOC 26022 |
| TIAZAC Diltiazem Hcl 2 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
4 Jun 2021 NOC 26000 |
| ZYBAN Bupropion Hydrochloride 7 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
4 Jun 2021 NOC 25992 |
| TIAZAC XC Diltiazem Hcl 2 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
4 Jun 2021 NOC 25991 |
| ADVATE Antihemophilic Factor (recombinant) |
Takeda Canada Inc | Biologic Labelling Only |
27 May 2021 NOC 25960 |
| TEPMETKO Tepotinib Hydrochloride 3 clinical trials → |
Emd Serono A Division Of Emd Inc Canada | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
27 May 2021 NOC 25946 |
| ABECMA Idecabtagene Vicleucel 5 clinical trials → |
Celgene Inc | Biologic Priority-NAS · with conditions |
26 May 2021 NOC 25936 |
| WAKIX Pitolisant Hydrochloride 4 clinical trials → |
Endo Ventures Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
25 May 2021 NOC 28132 |
| ILUMYA Tildrakizumab 6 clinical trials → |
Sun Pharma Global Fze | Biologic New Active Substance (NAS) |
19 May 2021 NOC 25900 |
| OCTASA Mesalazine 4 clinical trials → |
Tillotts Pharma Ag | Prescription Pharmaceutical Other |
18 May 2021 NOC 25889 |
| SUNOSI Solriamfetol Hydrochloride 7 clinical trials → |
Jazz Pharmaceuticals Ireland Limited | Prescription Pharmaceutical New Active Substance (NAS) |
13 May 2021 NOC 25861 |
| ANTITHROMBIN III NF (AT III NF) Antithrombin Iii (human) |
Takeda Canada Inc | Biologic Labelling Only |
30 Apr 2021 NOC 25797 |
| INPROSUB Progesterone 9 clinical trials → |
Ibsa Institut Biochimique Sa | Prescription Pharmaceutical Other |
30 Apr 2021 NOC 25767 |
| VYXEOS Cytarabine, Daunorubicin |
Jazz Pharmaceuticals Ireland Limited | Prescription Pharmaceutical Priority |
29 Apr 2021 NOC 25757 |
| PONVORY Ponesimod 3 clinical trials → |
Janssen Inc | Prescription Pharmaceutical New Active Substance (NAS) |
28 Apr 2021 NOC 25744 |
| TRIFERIC AVNU Ferric Pyrophosphate Citrate |
Rockwell Medical Inc | Prescription Pharmaceutical New Active Substance (NAS) |
22 Apr 2021 NOC 25714 |
| WAYMADE-TRIENTINE Trientine Hydrochloride |
Waymade Plc | Prescription Pharmaceutical New Active Substance (NAS) |
20 Apr 2021 NOC 25729 |
| FENOFIBRATE Fenofibrate 10 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
16 Apr 2021 NOC 25682 |
| ENHERTU Trastuzumab Deruxtecan 89 clinical trials → |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) · with conditions |
15 Apr 2021 NOC 25694 |
| EVRYSDI Risdiplam 6 clinical trials → |
Hoffmann La Roche Limited | Prescription Pharmaceutical Priority-NAS |
14 Apr 2021 NOC 25680 |
| APO-AMOXICILLIN Amoxicillin 23 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
13 Apr 2021 NOC 25652 |
| BRYHALI Halobetasol Propionate |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
13 Apr 2021 NOC 25649 |
| GAMMAGARD S/D Immunoglobulin (human) |
Takeda Canada Inc | Biologic Labelling Only |
9 Apr 2021 NOC 25790 |
| APO-DOXYCYCLINE MR Doxycycline Monohydrate 10 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
9 Apr 2021 NOC 25633 |
| KETOCONAZOLE Ketoconazole |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
7 Apr 2021 NOC 25610 |
| BRAFTOVI Encorafenib 21 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical Other |
30 Mar 2021 NOC 25546 |
| BENZACLIN Benzoyl Peroxide, Clindamycin Phosphate |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
29 Mar 2021 NOC 25554 |
| VISTASEAL Fibrinogen (human), Thrombin (human) |
Instituto Grifols S.a. | Biologic Other |
25 Mar 2021 NOC 25549 |
| SOMATULINE AUTOGEL Lanreotide 5 clinical trials → |
Ipsen Biopharmaceuticals Canada Inc | Prescription Pharmaceutical Labelling Only |
25 Mar 2021 NOC 25528 |
| LIPRELOG Insulin Lispro 2 clinical trials → |
Eli Lilly Canada Inc | Biologic Labelling Only |
22 Mar 2021 NOC 25516 |
| GAMMAGARD LIQUID Immunoglobulin (human) |
Takeda Canada Inc | Biologic Labelling Only |
18 Mar 2021 NOC 25482 |
| RIXUBIS Nonacog Gamma |
Takeda Canada Inc | Prescription Pharmaceutical Labelling Only |
12 Mar 2021 NOC 25438 |
| RIABNI Rituximab 239 clinical trials → |
Amgen Canada Inc | Biologic Other |
11 Mar 2021 NOC 25426 |
| OXYBUTYNIN, OXYBUTYNIN SYRUP Oxybutynin Chloride 5 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
10 Mar 2021 NOC 25411 |
| METFORMIN Metformin 105 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
8 Mar 2021 NOC 25389 |
| NEXTSTELLIS Drospirenone, Estetrol Monohydrate |
Searchlight Pharma Inc | Prescription Pharmaceutical New Active Substance (NAS) |
5 Mar 2021 NOC 25353 |
| MEKTOVI Binimetinib 20 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
2 Mar 2021 NOC 25334 |
| BRAFTOVI Encorafenib 21 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
2 Mar 2021 NOC 25329 |
| PHESGO Trastuzumab, Pertuzumab |
Hoffmann La Roche Limited | Biologic Other |
1 Mar 2021 NOC 25323 |
| BRUKINSA Zanubrutinib 62 clinical trials → |
Beigene Switzerland Gmbh | Prescription Pharmaceutical Priority-NAS |
1 Mar 2021 NOC 25315 |
| REPLAGAL Agalsidase Alfa |
Takeda Canada Inc | Biologic Labelling Only |
19 Feb 2021 NOC 25265 |
| CUVITRU Immunoglobulin (human) |
Takeda Canada Inc | Biologic Labelling Only |
19 Feb 2021 NOC 25264 |
| MEZAVANT Mesalazine 4 clinical trials → |
Takeda Canada Inc | Prescription Pharmaceutical Labelling Only |
19 Feb 2021 NOC 25255 |
| CEQUA Cyclosporine 13 clinical trials → |
Sun Pharma Global Fze | Prescription Pharmaceutical Other |
16 Feb 2021 NOC 25234 |
| DOJOLVI Triheptanoin |
Ultragenyx Pharmaceutical Inc | Prescription Pharmaceutical Priority-NAS |
15 Feb 2021 NOC 25214 |
| ACYCLOVIR Acyclovir 4 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
12 Feb 2021 NOC 25210 |
| ELAPRASE Idursulfase 2 clinical trials → |
Takeda Canada Inc | Biologic Other |
11 Feb 2021 NOC 25223 |
| REBLOZYL Luspatercept 28 clinical trials → |
Celgene Inc | Biologic Other |
11 Feb 2021 NOC 25187 |
| VITAMIN D3 ORAL SOLUTION Vitamin D3 |
Galephar Pharmaceutical Research Inc | Prescription Pharmaceutical Other |
5 Feb 2021 NOC 25162 |
| IMMUNINE VH Coagulation Factor Ix (human) |
Takeda Canada Inc | Biologic Labelling Only |
4 Feb 2021 NOC 25153 |
| VONVENDI Von Willebrand Factor (recombinant) |
Takeda Canada Inc | Biologic Labelling Only |
4 Feb 2021 NOC 25148 |
| KESIMPTA Ofatumumab 11 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Biologic Other |
22 Jan 2021 NOC 25064 |
| FLUOXETINE Fluoxetine Hydrochloride 10 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
19 Jan 2021 NOC 25033 |
| TERAZOSIN Terazosin Hcl |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
18 Jan 2021 NOC 25031 |
| ADYNOVATE Antihemophilic Factor (recombinant), Pegylated |
Shire Pharma Canada Ulc | Biologic Labelling Only |
15 Jan 2021 NOC 25021 |
| TISSUEBLUE Brilliant Blue G |
Dutch Ophthalmic Research Center International Bv | Prescription Pharmaceutical New Active Substance (NAS) |
15 Jan 2021 NOC 25018 |
| ADALIMUMAB INJECTION Adalimumab 35 clinical trials → |
Pfizer Canada Ulc | Biologic Other |
14 Jan 2021 NOC 25020 |
| SUPEMTEK Recombinant Haemagglutinin Protein-strain A(h1n1), Recombinant Haemagglutinin Protein-strain A(h3n2), Recombinant Haemagglutinin Protein-strain B (yamagata), Recombinant Haemagglutinin Protein-strain B (victoria) |
Sanofi Pasteur Limited | Biologic New Active Substance (NAS) |
14 Jan 2021 NOC 25019 |
| VYEPTI Eptinezumab 6 clinical trials → |
Lundbeck Canada Inc | Biologic New Active Substance (NAS) |
11 Jan 2021 NOC 24987 |
| ALTACE Ramipril 6 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
11 Jan 2021 NOC 24970 |
| FOCLIVIA Neuraminidase Antigen, Haemagglutinin |
Seqirus Uk Limited | Biologic Other |
7 Jan 2021 NOC 24962 |
| FOSRENOL Lanthanum Carbonate Hydrate |
Takeda Canada Inc | Prescription Pharmaceutical Labelling Only |
6 Jan 2021 NOC 24936 |
| ZIRABEV Bevacizumab 400 clinical trials → |
Pfizer Canada Ulc | Biologic Other |
5 Jan 2021 NOC 24933 |
| ONUREG Azacitidine 127 clinical trials → |
Celgene Inc | Prescription Pharmaceutical Priority |
5 Jan 2021 NOC 24927 |
| QVAR Beclomethasone Dipropionate |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
1 Jan 2021 NOC 24909 |
| CORZYNA Ranolazine 2 clinical trials → |
Kye Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS |
31 Dec 2020 NOC 24908 |
| REVESTIVE Teduglutide 2 clinical trials → |
Takeda Canada Inc | Biologic Labelling Only |
30 Dec 2020 NOC 24928 |
| XERESE Acyclovir, Hydrocortisone |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
30 Dec 2020 NOC 24903 |
| ESSEPNA L-alanine, Glycine, Histidine, L-arginine, L-isoleucine, L-leucine, L-phenylalanine, L-proline |
Fresenius Kabi Canada Ltd | Prescription Pharmaceutical Other |
30 Dec 2020 NOC 24899 |
| OMVYENCE Infliximab 39 clinical trials → |
Janssen Inc | Biologic Labelling Only |
29 Dec 2020 NOC 24929 |
| VERITY-BCG Bacillus Calmette-guÉrin (bcg) - Strain Russian Bcg-i |
Verity Pharmaceuticals Inc | Biologic Other · with conditions |
24 Dec 2020 NOC 24896 |
| ZOVIRAX Acyclovir 4 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
22 Dec 2020 NOC 24879 |
| AIROMIR Salbutamol Sulfate 4 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
22 Dec 2020 NOC 24864 |
| VPRIV Velaglucerase Alfa |
Takeda Canada Inc | Biologic Labelling Only |
21 Dec 2020 NOC 24865 |
| ADDERALL XR Amphetamine Aspartate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate |
Takeda Canada Inc | Prescription Pharmaceutical Labelling Only |
21 Dec 2020 NOC 24850 |
| CINRYZE C1 Esterase Inhibitor (human) |
Takeda Canada Inc | Biologic Labelling Only |
18 Dec 2020 NOC 24878 |
| BUSPIRONE Buspirone Hcl 2 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
18 Dec 2020 NOC 24824 |
| INCRELEX Mecasermin |
Ipsen Biopharmaceuticals Canada Inc | Biologic New Active Substance (NAS) |
17 Dec 2020 NOC 24820 |
| CYCLOBENZAPRINE Cyclobenzaprine Hydrochloride |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
16 Dec 2020 NOC 24811 |
| FIRAZYR Icatibant Acetate |
Takeda Canada Inc | Prescription Pharmaceutical Labelling Only |
16 Dec 2020 NOC 24810 |
| MEGESTROL Megestrol Acetate 12 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
16 Dec 2020 NOC 24805 |
| CLONAZEPAM Clonazepam 2 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
15 Dec 2020 NOC 24803 |
| ZOLGENSMA Onasemnogene Abeparvovec |
Novartis Pharmaceuticals Canada Inc | Biologic Priority-NAS |
15 Dec 2020 NOC 24801 |
| PROPADERM Beclomethasone Dipropionate |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
14 Dec 2020 NOC 24794 |
| LODALIS Colesevelam Hydrochloride 2 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
9 Dec 2020 NOC 24768 |
| TEMAZEPAM Temazepam |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
8 Dec 2020 NOC 24760 |
| REDESCA / REDESCA HP Enoxaparin Sodium 22 clinical trials → |
Shenzhen Techdow Pharmaceutical Co Ltd | Biologic Other |
7 Dec 2020 NOC 24766 |
| INTUNIV XR Guanfacine Hcl |
Takeda Canada Inc | Prescription Pharmaceutical Labelling Only |
4 Dec 2020 NOC 24849 |
| DERMATOP EMOLLIENT CREAM, DERMATOP OINTMENT Prednicarbate |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
3 Dec 2020 NOC 24744 |
| LOPROX Ciclopirox Olamine |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
27 Nov 2020 NOC 24698 |
| SODIUM PERTECHNETATE 99MTC INJECTION Sodium Pertechnetate Tc-99m |
Bc Cancer, Part Of The Provincial Health Services Authority | Radiopharmaceutical Other |
26 Nov 2020 NOC 24691 |
| TIROSINT Levothyroxine Sodium 7 clinical trials → |
Ibsa Institut Biochimique Sa | Prescription Pharmaceutical Other |
25 Nov 2020 NOC 24674 |
| HULIO Adalimumab 35 clinical trials → |
Bgp Pharma Ulc | Biologic Other |
24 Nov 2020 NOC 24670 |
| PERSERIS Risperidone 8 clinical trials → |
Hls Therapeutics Inc | Prescription Pharmaceutical Other |
19 Nov 2020 NOC 24647 |
| TAVALISSE Fostamatinib Disodium |
Rigel Pharmaceuticals Inc. | Prescription Pharmaceutical New Active Substance (NAS) |
19 Nov 2020 NOC 24636 |
| INCLUNOX, INCLUNOX HP Enoxaparin Sodium 22 clinical trials → |
Sandoz Canada Incorporated | Biologic Other |
5 Nov 2020 NOC 24570 |
| HYRIMOZ Adalimumab 35 clinical trials → |
Sandoz Canada Incorporated | Biologic Other |
4 Nov 2020 NOC 24564 |
| DAYVIGO Lemborexant 11 clinical trials → |
Eisai Limited | Prescription Pharmaceutical New Active Substance (NAS) |
4 Nov 2020 NOC 24557 |
| AMGEVITA Adalimumab 35 clinical trials → |
Amgen Canada Inc | Biologic Other |
4 Nov 2020 NOC 24554 |
| LOSEC Omeprazole 13 clinical trials → |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
2 Nov 2020 NOC 24528 |
| LOSEC Omeprazole Magnesium 13 clinical trials → |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
2 Nov 2020 NOC 24527 |
| ZYCLARA Imiquimod 5 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
30 Oct 2020 NOC 24529 |
| IDACIO Adalimumab 35 clinical trials → |
Fresenius Kabi Canada Ltd | Biologic Other |
30 Oct 2020 NOC 24521 |
| MENQUADFI Meningococcal Group A Polysaccharide-tetanus Toxoid Conjugate, Meningococcal Group C Polysaccharide-tetanus Toxoid Conjugate, Meningococcal Group W Polysaccharide-tetanus Toxoid Conjugate, Meningococcal Group Y Polysaccharide-tetanus Toxoid Conjugate |
Sanofi Pasteur Limited | Biologic Other |
29 Oct 2020 NOC 24522 |
| NYVEPRIA Pegfilgrastim 18 clinical trials → |
Pfizer Canada Ulc | Biologic Other |
28 Oct 2020 NOC 24510 |
| TRURAPI Insulin Aspart 3 clinical trials → |
Sanofi-aventis Canada Inc | Biologic Other |
15 Oct 2020 NOC 24472 |
| NOROMBY, NOROMBY HP Enoxaparin Sodium 22 clinical trials → |
Juno Pharmaceuticals Corp. | Biologic Other |
14 Oct 2020 NOC 24439 |
| LUXTURNA Voretigene Neparvovec |
Novartis Pharmaceuticals Canada Inc | Biologic New Active Substance (NAS) |
13 Oct 2020 NOC 24429 |
| GIVLAARI Givosiran |
Alnylam Netherlands B.v. | Prescription Pharmaceutical Priority-NAS |
9 Oct 2020 NOC 24422 |
| VOCARVI Foscarnet Sodium |
Sterimax Inc | Prescription Pharmaceutical Other |
5 Oct 2020 NOC 24369 |
| ZEPOSIA Ozanimod Hydrochloride 10 clinical trials → |
Celgene Inc | Prescription Pharmaceutical New Active Substance (NAS) |
2 Oct 2020 NOC 24355 |
| BENZAMYCIN Benzoyl Peroxide, Erythromycin |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
1 Oct 2020 NOC 24342 |
| RETIN-A MICRO Tretinoin 4 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
30 Sep 2020 NOC 24341 |
| VITAMIN A ACID Tretinoin 4 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
30 Sep 2020 NOC 24340 |
| FEIBA NF Feiba (factor Eight Inhibitor Bypassing Activity) |
Takeda Canada Inc | Biologic Labelling Only |
29 Sep 2020 NOC 24900 |
| REBLOZYL Luspatercept 28 clinical trials → |
Celgene Inc | Biologic Priority-NAS |
25 Sep 2020 NOC 24315 |
| BIVALIRUDIN INJECTION Bivalirudin 2 clinical trials → |
Avir Pharma Inc | Prescription Pharmaceutical Other |
24 Sep 2020 NOC 24290 |
| BIJUVA Progesterone, Estradiol Hemihydrate |
Knight Therapeutics Inc. | Prescription Pharmaceutical Other |
17 Sep 2020 NOC 24246 |
| MAR-TRIENTINE Trientine Hydrochloride |
Marcan Pharmaceuticals Inc | Prescription Pharmaceutical New Active Substance (NAS) |
14 Sep 2020 NOC 24221 |
| GLEOLAN 5-aminolevulinic Acid |
Medexus Inc | Prescription Pharmaceutical Priority |
9 Sep 2020 NOC 24192 |
| GALLIAPHARM Gallium (68ga) Chloride, Germanium (68ge) Chloride |
Eckert & Ziegler Radiopharma Gmbh | Radiopharmaceutical New Active Substance (NAS) |
19 Aug 2020 NOC 24092 |
| IMVEXXY Estradiol Hemihydrate 11 clinical trials → |
Knight Therapeutics Inc. | Prescription Pharmaceutical Other |
17 Aug 2020 NOC 24067 |
| FIRDAPSE Amifampridine (supplied As Amifampridine Phosphate) |
Catalyst Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS |
31 Jul 2020 NOC 23996 |
| SANI-CIDE EX3 L-lactic Acid |
Celeste Industries Corporation | Nonprescription Pharmaceutical Other |
30 Jul 2020 NOC 23993 |
| ANTHIM Obiltoxaximab |
Elusys Therapeutics Inc | Biologic New Active Substance (NAS) |
30 Jul 2020 NOC 23982 |
| INREBIC Fedratinib Hydrochloride 3 clinical trials → |
Celgene Inc | Prescription Pharmaceutical New Active Substance (NAS) |
27 Jul 2020 NOC 23965 |
| VEKLURY Remdesivir 5 clinical trials → |
Gilead Sciences Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
27 Jul 2020 NOC 23963 |
| TOMVI Etomidate 2 clinical trials → |
Sterimax Inc | Prescription Pharmaceutical New Active Substance (NAS) |
16 Jul 2020 NOC 23917 |
| XENLETA Lefamulin Acetate |
Sunovion Pharmaceuticals Canada Inc | Prescription Pharmaceutical Priority-NAS |
10 Jul 2020 NOC 23888 |
| POLIVY Polatuzumab Vedotin 23 clinical trials → |
Hoffmann La Roche Limited | Biologic New Active Substance (NAS) · with conditions |
9 Jul 2020 NOC 23883 |
| INQOVI Decitabine, Cedazuridine |
Otsuka Pharmaceutical Co Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
7 Jul 2020 NOC 23869 |
| ENERZAIR BREEZHALER Mometasone Furoate, Glycopyrronium Bromide, Indacaterol Acetate |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical Other |
2 Jul 2020 NOC 23854 |
| QINLOCK Ripretinib 4 clinical trials → |
Deciphera Pharmaceuticals. Llc | Prescription Pharmaceutical Priority-NAS |
19 Jun 2020 NOC 23819 |
| KYNMOBI Apomorphine Hcl |
Sunovion Pharmaceuticals Canada Inc | Prescription Pharmaceutical Other |
12 Jun 2020 NOC 23773 |
| ODOMZO Sonidegib 2 clinical trials → |
Sun Pharma Global Fze | Prescription Pharmaceutical New Active Substance (NAS) |
12 Jun 2020 NOC 23772 |
| DUOBRII Halobetasol Propionate, Tazarotene |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Other |
10 Jun 2020 NOC 23758 |
| REVATIO Sildenafil Citrate 13 clinical trials → |
Upjohn Canada Ulc | Prescription Pharmaceutical Labelling Only |
5 Jun 2020 NOC 23738 |
| LOSEC MUPS Omeprazole 13 clinical trials → |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
5 Jun 2020 NOC 23737 |
| TUKYSA Tucatinib 20 clinical trials → |
Seattle Genetics Inc | Prescription Pharmaceutical Priority-NAS |
5 Jun 2020 NOC 23735 |
| CONTRAVE Naloxone Hydrochloride, Bupropion Hydrochloride |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
5 Jun 2020 NOC 23702 |
| SUPREFACT Buserelin Acetate 2 clinical trials → |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
4 Jun 2020 NOC 23725 |
| SUPREFACT DEPOT 2 MONTHS, SUPREFACT DEPOT 3 MONTHS Buserelin Acetate 2 clinical trials → |
Cheplapharm Arzneimittel Gmbh | Prescription Pharmaceutical Labelling Only |
4 Jun 2020 NOC 23724 |
| ACZONE Dapsone 2 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
4 Jun 2020 NOC 23723 |
| ENSPRYNG Satralizumab 8 clinical trials → |
Hoffmann La Roche Limited | Biologic Priority-NAS |
1 Jun 2020 NOC 23701 |
| NEXPLANON Etonogestrel |
Merck Canada Inc | Prescription Pharmaceutical Other |
25 May 2020 NOC 23666 |
| SIGNIFOR Pasireotide |
Recordati Rare Diseases Canada Inc | Prescription Pharmaceutical Labelling Only |
21 May 2020 NOC 23644 |
| SIGNIFOR LAR Pasireotide |
Recordati Rare Diseases Canada Inc | Prescription Pharmaceutical Labelling Only |
21 May 2020 NOC 23639 |
| SPRAVATO Esketamine Hydrochloride 46 clinical trials → |
Janssen Inc | Prescription Pharmaceutical Priority |
20 May 2020 NOC 23645 |
| SANDOZ LEVODOPA-CARBIDOPA-ENTACAPONE Carbidopa, Levodopa, Entacapone |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
15 May 2020 NOC 23617 |
| ATECTURA BREEZHALER Mometasone Furoate, Indacaterol Acetate |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical Other |
6 May 2020 NOC 23552 |
| ROZLYTREK Entrectinib 14 clinical trials → |
Hoffmann La Roche Limited | Prescription Pharmaceutical Other |
5 May 2020 NOC 23549 |
| RUXIENCE Rituximab 239 clinical trials → |
Pfizer Canada Ulc | Biologic Other |
4 May 2020 NOC 23545 |
| AA-DILTIAZ Diltiazem Hcl 2 clinical trials → |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
30 Apr 2020 NOC 23544 |
| SARCLISA Isatuximab 36 clinical trials → |
Sanofi-aventis Canada Inc | Biologic New Active Substance (NAS) |
29 Apr 2020 NOC 23530 |
| RIXIMYO Rituximab 239 clinical trials → |
Sandoz Canada Incorporated | Biologic Other |
28 Apr 2020 NOC 23519 |
| DAURISMO Glasdegib |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
28 Apr 2020 NOC 23517 |
| ZIEXTENZO Pegfilgrastim 18 clinical trials → |
Sandoz Canada Incorporated | Biologic Other |
21 Apr 2020 NOC 23492 |
| NIVESTYM Filgrastim (r-methug-csf) |
Pfizer Canada Ulc | Biologic Other |
16 Apr 2020 NOC 23487 |
| UCERIS Budesonide 11 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Other |
15 Apr 2020 NOC 23460 |
| IBSRELA Tenapanor 2 clinical trials → |
Knight Therapeutics Inc. | Prescription Pharmaceutical New Active Substance (NAS) |
15 Apr 2020 NOC 23453 |
| ITULATEK Standardized Allergen Extract, White Birch (betula Verrucosa) |
Alk - Abello A/s | Biologic Other |
15 Apr 2020 NOC 23452 |
| AJOVY Fremanezumab 4 clinical trials → |
Teva Canada Limited | Biologic New Active Substance (NAS) |
9 Apr 2020 NOC 23441 |
| LYSODREN Mitotane |
Hra Pharma Rare Diseases | Prescription Pharmaceutical Labelling Only |
3 Apr 2020 NOC 23421 |
| ADDNUTRIV Chromic Chloride, Ferric Chloride, Cupric Chloride, Manganese Chloride, Potassium Iodide, Sodium Fluoride, Sodium Selenite, Sodium Molybdate |
Fresenius Kabi Canada Ltd | Nonprescription Pharmaceutical Other |
1 Apr 2020 NOC 23406 |
| RYBELSUS Semaglutide 110 clinical trials → |
Novo Nordisk Canada Inc | Biologic Other |
30 Mar 2020 NOC 23396 |
| AA-LEVOCARB CR Carbidopa, Levodopa |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
24 Mar 2020 NOC 23384 |
| CABENUVA, VOCABRIA Cabotegravir, Rilpivirine |
Viiv Healthcare Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
18 Mar 2020 NOC 23362 |
| BEOVU Brolucizumab |
Novartis Pharmaceuticals Canada Inc | Biologic New Active Substance (NAS) |
12 Mar 2020 NOC 23336 |
| AVSOLA Infliximab 39 clinical trials → |
Amgen Canada Inc | Biologic Other |
12 Mar 2020 NOC 23329 |
| PIQRAY Alpelisib 22 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
11 Mar 2020 NOC 23331 |
| PEYONA Caffeine Citrate 11 clinical trials → |
Chiesi Farmaceutici S.p.a. | Prescription Pharmaceutical Other |
4 Mar 2020 NOC 23291 |
| REGIOCIT Sodium Chloride, Sodium Citrate |
Baxter Corporation | Prescription Pharmaceutical Other |
3 Mar 2020 NOC 23292 |
| CABLIVI Caplacizumab |
Sanofi-aventis Canada Inc | Biologic Priority-NAS |
28 Feb 2020 NOC 23316 |
| SUVEXX Naproxen Sodium, Sumatriptan Succinate |
Aralez Pharmaceuticals Canada Inc | Prescription Pharmaceutical Other |
27 Feb 2020 NOC 23258 |
| KANJINTI Trastuzumab 128 clinical trials → |
Amgen Canada Inc | Biologic Other |
27 Feb 2020 NOC 23256 |
| NUBEQA Darolutamide 54 clinical trials → |
Bayer Inc | Prescription Pharmaceutical New Active Substance (NAS) |
20 Feb 2020 NOC 23233 |
| MAYZENT Siponimod 3 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
20 Feb 2020 NOC 23232 |
| XOFLUZA Baloxavir Marboxil 6 clinical trials → |
Hoffmann La Roche Limited | Prescription Pharmaceutical New Active Substance (NAS) |
19 Feb 2020 NOC 23228 |
| ROZLYTREK Entrectinib 14 clinical trials → |
Hoffmann La Roche Limited | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
10 Feb 2020 NOC 23189 |
| SANDOZ EVEROLIMUS Everolimus 53 clinical trials → |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
28 Jan 2020 NOC 23156 |
| TEVA-BETAMETHASONE / CALCIPOTRIOL Betamethasone Dipropionate, Calcipotriol |
Teva Canada Limited | Prescription Pharmaceutical Other |
28 Jan 2020 NOC 23152 |
| AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION Amoxicillin, Clavulanic Acid |
Sandoz Canada Incorporated | Prescription Pharmaceutical Other |
28 Jan 2020 NOC 23151 |
| ELIDEL Pimecrolimus 3 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
20 Jan 2020 NOC 23119 |
| VYNDAQEL Tafamidis Meglumine |
Pfizer Canada Ulc | Prescription Pharmaceutical Priority-NAS |
20 Jan 2020 NOC 23118 |
| OSNUVO Teriparatide 4 clinical trials → |
Avir Pharma Inc | Biologic Other |
13 Jan 2020 NOC 23106 |
| VASCEPA Icosapent Ethyl 4 clinical trials → |
Hls Therapeutics Inc | Prescription Pharmaceutical Priority-NAS |
30 Dec 2019 NOC 23058 |
| SANDOZ CLOBETASOL Clobetasol Propionate 3 clinical trials → |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
23 Dec 2019 NOC 23051 |
| XOSPATA Gilteritinib Fumarate 16 clinical trials → |
Astellas Pharma Canada Inc | Prescription Pharmaceutical Priority-NAS |
23 Dec 2019 NOC 23047 |
| RINVOQ Upadacitinib 40 clinical trials → |
Abbvie Corporation | Prescription Pharmaceutical New Active Substance (NAS) |
23 Dec 2019 NOC 23046 |
| IBUPROFEN Ibuprofen 22 clinical trials → |
Jamp Pharma Corporation | Nonprescription Pharmaceutical Labelling Only |
16 Dec 2019 NOC 23030 |
| CUPRIMINE D-penicillamine |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
13 Dec 2019 NOC 23014 |
| PMS-FLUTICASONE PROPIONATE/SALMETEROL DPI Fluticasone Propionate, Salmeterol Xinafoate |
Pharmascience Inc | Prescription Pharmaceutical Labelling Only |
10 Dec 2019 NOC 23260 |
| XEMBIFY Immunoglobulin (human) |
Grifols Therapeutics Llc | Biologic Other |
10 Dec 2019 NOC 22997 |
| MYLOTARG Gemtuzumab Ozogamicin 7 clinical trials → |
Pfizer Canada Ulc | Biologic New Active Substance (NAS) |
28 Nov 2019 NOC 22957 |
| AKLIEF Trifarotene |
Galderma Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
25 Nov 2019 NOC 22942 |
| FLUCELVAX QUAD Haemagglutinin-strain A(h1n1), Haemagglutinin-strain A(h3n2), Haemagglutinin-strain B(victoria), Haemagglutinin-strain B(yamagata) |
Seqirus Uk Limited | Biologic Other |
22 Nov 2019 NOC 22932 |
| SANDOZ BISOPROLOL TABLETS Bisoprolol Fumarate 3 clinical trials → |
Sandoz Canada Incorporated | Prescription Pharmaceutical Other |
18 Nov 2019 NOC 22906 |
| GALLI EO Gallium (68ga) Chloride |
Ire Elit S.a. | Radiopharmaceutical New Active Substance (NAS) |
13 Nov 2019 NOC 23094 |
| JORVEZA Budesonide 11 clinical trials → |
Avir Pharma Inc | Prescription Pharmaceutical Priority |
6 Nov 2019 NOC 22861 |
| INTRAROSA Prasterone |
Endoceutics Inc | Prescription Pharmaceutical New Active Substance (NAS) |
1 Nov 2019 NOC 23288 |
| BAR-BUPRENORPHINE Buprenorphine 5 clinical trials → |
Bard Pharmaceuticals (1990) Inc | Prescription Pharmaceutical Labelling Only |
1 Nov 2019 NOC 22849 |
| LORATADINE SOFT GELATIN CAPSULES Loratadine 2 clinical trials → |
Catalent Ontario Limited | Nonprescription Pharmaceutical Other |
31 Oct 2019 NOC 22842 |
| BALVERSA Erdafitinib 8 clinical trials → |
Janssen Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
25 Oct 2019 NOC 22821 |
| EVEROLIMUS Everolimus 53 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical Labelling Only |
18 Oct 2019 NOC 22960 |
| NETILDEX (WITH PRESERVATIVE), NETILDEX (WITHOUT PRESERVATIVE) Dexamethasone Sodium Phosphate, Netilmicin Sulfate |
Knight Therapeutics Inc. | Prescription Pharmaceutical Other |
18 Oct 2019 NOC 22794 |
| IBUPROFEN Ibuprofen 22 clinical trials → |
Jamp Pharma Corporation | Nonprescription Pharmaceutical Labelling Only |
11 Oct 2019 NOC 22792 |
| AA-FENO-MICRO, FENOFIBRATE Fenofibrate 10 clinical trials → |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
11 Oct 2019 NOC 22776 |
| TRULANCE Plecanatide |
Cipher Pharmaceuticals Inc | Prescription Pharmaceutical New Active Substance (NAS) |
10 Oct 2019 NOC 22769 |
| MINOCYCLINE Minocycline Hcl 6 clinical trials → |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
27 Sep 2019 NOC 22723 |
| BAQSIMI Glucagon 2 clinical trials → |
Eli Lilly Canada Inc | Nonprescription Pharmaceutical Other |
25 Sep 2019 NOC 22694 |
| SANDOZ FLUVASTATIN XL Fluvastatin Sodium |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
24 Sep 2019 NOC 22689 |
| SSP+ Potassium Chloride, Sodium Phosphate Monobasic, Sodium Chloride, Sodium Acetate Trihydrate, Sodium Phosphate Dibasic, Magnesium Chloride Hexahydrate, Sodium Citrate Dihydrate, Water |
Maco Pharma | Biologic Other |
19 Sep 2019 NOC 22757 |
| SODIUM IODIDE I-123 ORAL SOLUTION Sodium Iodide 123 I |
Bwxt Itg Canada Inc. | Radiopharmaceutical Labelling Only |
19 Sep 2019 NOC 22721 |
| FINACEA Azelaic Acid |
Leo Pharma Inc | Prescription Pharmaceutical Labelling Only |
18 Sep 2019 NOC 22678 |
| TALZENNA Talazoparib 12 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
6 Sep 2019 NOC 22615 |
| HERZUMA Trastuzumab 128 clinical trials → |
Celltrion Healthcare Co Ltd | Biologic Other |
3 Sep 2019 NOC 22614 |
| ULTOMIRIS Ravulizumab 15 clinical trials → |
Alexion Pharma Gmbh | Biologic New Active Substance (NAS) |
28 Aug 2019 NOC 22577 |
| CALQUENCE Acalabrutinib 48 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
23 Aug 2019 NOC 22572 |
| DOVATO Lamivudine, Dolutegravir |
Viiv Healthcare Ulc | Prescription Pharmaceutical Other |
22 Aug 2019 NOC 22566 |
| NYSTATIN/ COLISTIN/ TOBRAMYCIN | Sunnybrook Research Institute | Prescription Pharmaceutical Other |
16 Aug 2019 NOC 22538 |
| TRAZIMERA Trastuzumab 128 clinical trials → |
Pfizer Canada Ulc | Biologic Other |
15 Aug 2019 NOC 22542 |
| EMGALITY Galcanezumab 4 clinical trials → |
Eli Lilly Canada Inc | Biologic New Active Substance (NAS) |
30 Jul 2019 NOC 22485 |
| INHIBACE Cilazapril Monohydrate |
Cheplapharm Arzneimittel Gmbh Germany | Prescription Pharmaceutical Labelling Only |
29 Jul 2019 NOC 22471 |
| LOKELMA Sodium Zirconium Cyclosilicate 3 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
25 Jul 2019 NOC 22442 |
| NERLYNX Neratinib Maleate 7 clinical trials → |
Puma Biotechnology Inc | Prescription Pharmaceutical New Active Substance (NAS) |
16 Jul 2019 NOC 22406 |
| PRO-NAPROXEN EC Naproxen 2 clinical trials → |
Pro Doc Limitee | Prescription Pharmaceutical Labelling Only |
12 Jul 2019 NOC 22399 |
| PDP-LEVETIRACETAM Levetiracetam 13 clinical trials → |
Pendopharm Division Of Pharmascience Inc | Prescription Pharmaceutical Other |
11 Jul 2019 NOC 22397 |
| DACOGEN Decitabine 51 clinical trials → |
Otsuka Pharmaceutical Co Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
11 Jul 2019 NOC 22390 |
| VITRAKVI Larotrectinib 9 clinical trials → |
Bayer Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
10 Jul 2019 NOC 22387 |
| ESPEROCT Antihemophilic Factor Viii (recombinant, B-domain Truncated), Pegylated |
Novo Nordisk Canada Inc | Biologic New Active Substance (NAS) |
4 Jul 2019 NOC 22386 |
| NETSPOT Oxodotreotide |
Advanced Accelerator Applications Usa, Inc. | Radiopharmaceutical New Active Substance (NAS) |
3 Jul 2019 NOC 22356 |
| SANDOZ DEFERASIROX (TYPE J) Deferasirox |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
2 Jul 2019 NOC 22353 |
| ZEJULA Niraparib 37 clinical trials → |
Glaxosmithkline Inc | Prescription Pharmaceutical New Active Substance (NAS) |
27 Jun 2019 NOC 22331 |
| METHIMAZOLE TABLETS USP Methimazole 3 clinical trials → |
Endo Ventures Ltd | Prescription Pharmaceutical Labelling Only |
25 Jun 2019 NOC 22323 |
| EVENITY Romosozumab 7 clinical trials → |
Amgen Canada Inc | Biologic New Active Substance (NAS) |
17 Jun 2019 NOC 22291 |
| ZIRABEV Bevacizumab 400 clinical trials → |
Pfizer Canada Ulc | Biologic Other |
14 Jun 2019 NOC 22292 |
| ARIDOL Mannitol 10 clinical trials → |
Pharmaxis Ltd | Prescription Pharmaceutical Other |
13 Jun 2019 NOC 22303 |
| FOSFOMYCIN POWDER FOR ORAL SOLUTION Fosfomycin Tromethamine |
Endo Ventures Ltd | Prescription Pharmaceutical Labelling Only |
13 Jun 2019 NOC 22280 |
| SILIQ Brodalumab 3 clinical trials → |
Bausch Health, Canada Inc. | Biologic Labelling Only |
7 Jun 2019 NOC 22254 |
| ONPATTRO Patisiran Sodium |
Alnylam Netherlands B.v. | Prescription Pharmaceutical Priority-NAS |
7 Jun 2019 NOC 22251 |
| GALDERMA ADAPALENE/BENZOYL PEROXIDE Benzoyl Peroxide, Adapalene |
Galderma Canada Inc | Prescription Pharmaceutical Labelling Only |
24 May 2019 NOC 22191 |
| TIBELLA Tibolone |
Biosyent Pharma Inc | Prescription Pharmaceutical New Active Substance (NAS) |
10 May 2019 NOC 22141 |
| NAPROXEN CAPSULES 200 MG Naproxen, Naproxen Sodium |
Apotex Inc | Nonprescription Pharmaceutical Labelling Only |
10 May 2019 NOC 22137 |
| COMBOGESIC Acetaminophen, Ibuprofen |
Aft Pharmaceuticals Ltd | Nonprescription Pharmaceutical Other |
9 May 2019 NOC 22136 |
| NORITATE Metronidazole 16 clinical trials → |
Bausch Health, Canada Inc. | Prescription Pharmaceutical Labelling Only |
7 May 2019 NOC 22133 |
| OGIVRI Trastuzumab 128 clinical trials → |
Bgp Pharma Ulc | Biologic Other |
3 May 2019 NOC 22118 |
| IVOZFO Fosfomycin Sodium 3 clinical trials → |
Verity Pharmaceuticals Inc | Prescription Pharmaceutical Priority |
1 May 2019 NOC 22103 |
| AA-THEO LA Theophylline 2 clinical trials → |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
30 Apr 2019 NOC 22106 |
| SKYRIZI Risankizumab 21 clinical trials → |
Abbvie Corporation | Biologic New Active Substance (NAS) |
17 Apr 2019 NOC 22070 |
| LIBTAYO Cemiplimab 68 clinical trials → |
Sanofi-aventis Canada Inc | Biologic New Active Substance (NAS) · with conditions |
10 Apr 2019 NOC 22053 |
| REACTINE ALLERGY Cetirizine Hydrochloride |
Mcneil Consumer Healthcare Division Of Johnson & Johnson Inc | Nonprescription Pharmaceutical Labelling Only |
5 Apr 2019 NOC 22072 |
| VERZENIO Abemaciclib 70 clinical trials → |
Eli Lilly Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
5 Apr 2019 NOC 22040 |
| TRUXIMA Rituximab 239 clinical trials → |
Celltrion Healthcare Co Ltd | Biologic Other |
4 Apr 2019 NOC 22041 |
| ACTONEL, ACTONEL DR Risedronate Sodium |
Allergan Inc | Prescription Pharmaceutical Labelling Only |
15 Mar 2019 NOC 21979 |
| AA-AMILZIDE Amiloride Hydrochloride, Hydrochlorothiazide |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
13 Mar 2019 NOC 23009 |
| XTORO Finafloxacin |
Merlion Pharmaceuticals Gmbh | Prescription Pharmaceutical Labelling Only |
11 Mar 2019 NOC 21952 |
| SANDOZ FINGOLIMOD Fingolimod Hydrochloride 8 clinical trials → |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
11 Mar 2019 NOC 21948 |
| MINESTRIN 1/20 Ethinyl Estradiol, Norethindrone Acetate |
Allergan Inc | Prescription Pharmaceutical Labelling Only |
1 Mar 2019 NOC 21913 |
| INFLUVAC TETRA Haemagglutinin-strain A(h1n1), Haemagglutinin-strain A(h3n2), Haemagglutinin-strain B(victoria), Haemagglutinin-strain B(yamagata) |
Bgp Pharma Ulc | Biologic Other |
1 Mar 2019 NOC 21911 |
| VIZIMPRO Dacomitinib 5 clinical trials → |
Pfizer Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
26 Feb 2019 NOC 21898 |
| LORBRENA Lorlatinib 20 clinical trials → |
Pfizer Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
22 Feb 2019 NOC 21896 |
| ENVARSUS PA Tacrolimus 40 clinical trials → |
Endo Ventures Ltd | Prescription Pharmaceutical Other |
15 Feb 2019 NOC 21868 |
| YESCARTA Axicabtagene Ciloleucel 13 clinical trials → |
Gilead Sciences Canada Inc | Biologic Priority-NAS |
13 Feb 2019 NOC 21857 |
| FLURBIPROFEN Flurbiprofen 3 clinical trials → |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
12 Feb 2019 NOC 21844 |
| CYSTADROPS Cysteamine Hydrochloride |
Recordati Rare Diseases Canada Inc | Prescription Pharmaceutical Priority |
11 Feb 2019 NOC 21855 |
| ENABLEX Darifenacin Hydrobromide |
Searchlight Pharma Inc | Prescription Pharmaceutical Labelling Only |
11 Feb 2019 NOC 21842 |
| OXERVATE Cenegermin 2 clinical trials → |
DompÉ Farmaceutici S.p.a. | Biologic Priority-NAS |
8 Feb 2019 NOC 21856 |
| IDHIFA Enasidenib Mesylate 8 clinical trials → |
Celgene Inc | Prescription Pharmaceutical Priority-NAS · with conditions |
6 Feb 2019 NOC 21837 |
| TOLAK Fluorouracil 94 clinical trials → |
Hill Dermaceuticals Inc | Prescription Pharmaceutical Other |
1 Feb 2019 NOC 21816 |
| ONCASPAR Pegaspargase 13 clinical trials → |
Servier Canada Inc | Biologic Labelling Only |
25 Jan 2019 NOC 21799 |
| VIIBRYD Vilazodone Hydrochloride |
Allergan Inc | Prescription Pharmaceutical Labelling Only |
24 Jan 2019 NOC 21789 |
| CIMETIDINE Cimetidine |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
22 Jan 2019 NOC 21774 |
| DEMYLOCAN Decitabine 51 clinical trials → |
Pendopharm Division Of Pharmascience Inc | Prescription Pharmaceutical New Active Substance (NAS) |
21 Jan 2019 NOC 21766 |
| SULFATRIM, SULFATRIM DS, SULFATRIM PEDIATRIC Sulfamethoxazole, Trimethoprim |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
18 Jan 2019 NOC 21791 |
| LOESTRIN 1.5/30 Ethinyl Estradiol, Norethindrone Acetate |
Allergan Inc | Prescription Pharmaceutical Labelling Only |
15 Jan 2019 NOC 21743 |
| PDP-AMLODIPINE Amlodipine Besylate 8 clinical trials → |
Pendopharm Division Of Pharmascience Inc | Prescription Pharmaceutical Other |
11 Jan 2019 NOC 21741 |
| ONSTRYV Safinamide |
Valeo Pharma Inc | Prescription Pharmaceutical New Active Substance (NAS) |
10 Jan 2019 NOC 21720 |
| DIAZEPAM Diazepam |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
10 Jan 2019 NOC 21718 |
| VONVENDI Von Willebrand Factor (recombinant), Vonicog Alfa |
Shire Pharma Canada Ulc | Biologic New Active Substance (NAS) |
10 Jan 2019 NOC 21714 |
| LUTATHERA Lutetium (177lu) Oxodotreotide 2 clinical trials → |
Advanced Accelerator Applications Usa, Inc. | Radiopharmaceutical Priority-NAS |
9 Jan 2019 NOC 21712 |
| ONIVYDE Irinotecan 140 clinical trials → |
Servier Canada Inc | Prescription Pharmaceutical Labelling Only |
4 Jan 2019 NOC 23242 |
| VYZULTA Latanoprostene Bunod |
Bausch & Lomb Inc | Prescription Pharmaceutical New Active Substance (NAS) |
27 Dec 2018 NOC 21680 |
| VERKAZIA Cyclosporine 13 clinical trials → |
Santen Incorporated | Prescription Pharmaceutical Priority |
24 Dec 2018 NOC 21681 |
| FULPHILA Pegfilgrastim 18 clinical trials → |
Bgp Pharma Ulc | Biologic Other |
24 Dec 2018 NOC 21665 |
| NAPROXEN CAPSULES 200 MG Naproxen, Naproxen Sodium |
Catalent Ontario Limited | Nonprescription Pharmaceutical Labelling Only |
21 Dec 2018 NOC 21658 |
| BRINEURA Cerliponase Alfa |
Biomarin International Limited | Biologic Priority-NAS |
19 Dec 2018 NOC 21637 |
| CRESEMBA Isavuconazonium Sulfate |
Avir Pharma Inc | Prescription Pharmaceutical New Active Substance (NAS) |
19 Dec 2018 NOC 21636 |
| BIOTHRAX Anthrax Antigen Filtrate |
Emergent Biodefense Operations Lansing Llc | Biologic New Active Substance (NAS) |
13 Dec 2018 NOC 21632 |
| CRYSVITA Burosumab |
Kyowa Kirin Limited | Biologic Priority-NAS |
5 Dec 2018 NOC 21604 |
| STRAMUCIN Mupirocin 2 clinical trials → |
Glenmark Pharmaceuticals Canada Inc. | Nonprescription Pharmaceutical Other |
29 Nov 2018 NOC 21586 |
| BELSOMRA Suvorexant |
Merck Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
29 Nov 2018 NOC 21585 |
| ACETAMINOPHEN INJECTION Acetaminophen 36 clinical trials → |
Avir Pharma Inc | Prescription Pharmaceutical Other |
29 Nov 2018 NOC 21576 |
| UNITUXIN Dinutuximab 5 clinical trials → |
United Therapeutics Corporation | Biologic New Active Substance (NAS) |
28 Nov 2018 NOC 21570 |
| ILUVIEN Fluocinolone Acetonide |
Knight Therapeutics Inc. | Prescription Pharmaceutical Other |
23 Nov 2018 NOC 21548 |
| SUBLOCADE Buprenorphine 5 clinical trials → |
Indivior Uk Limited | Prescription Pharmaceutical Priority |
21 Nov 2018 NOC 21545 |
| DELSTRIGO Lamivudine, Tenofovir Disoproxil Fumarate, Doravirine |
Merck Canada Inc | Prescription Pharmaceutical Other |
9 Nov 2018 NOC 21520 |
| LIDOCAINE HYDROCHLORIDE INJECTION USP Lidocaine Hydrochloride 58 clinical trials → |
Pfizer Canada Inc | Nonprescription Pharmaceutical Labelling Only |
9 Nov 2018 NOC 21519 |
| KAMRAB Rabies Immunoglobulin, Human |
Kamada Ltd | Biologic Other |
7 Nov 2018 NOC 21510 |
| FOLOTYN Pralatrexate 3 clinical trials → |
Servier Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
26 Oct 2018 NOC 21458 |
| ONDANSETRON ODT Ondansetron 17 clinical trials → |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
18 Oct 2018 NOC 21450 |
| JIVI Antihemophilic Factor (recombinant, B-domain Deleted, Pegylated), Damoctocog Alfa Pegol |
Bayer Inc | Biologic New Active Substance (NAS) |
18 Oct 2018 NOC 21437 |
| PERINDOPRIL ERBUMINE Perindopril Erbumine |
Sanis Health Inc | Prescription Pharmaceutical Labelling Only |
12 Oct 2018 NOC 21416 |
| PIFELTRO Doravirine 4 clinical trials → |
Merck Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
12 Oct 2018 NOC 21411 |
| XERMELO Telotristat Etiprate |
Ipsen Biopharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
10 Oct 2018 NOC 21406 |
| BYSTOLIC Nebivolol Hcl 4 clinical trials → |
Allergan Inc | Prescription Pharmaceutical Labelling Only |
5 Oct 2018 NOC 21394 |
| ORILISSA Elagolix |
Abbvie Corporation | Prescription Pharmaceutical New Active Substance (NAS) |
5 Oct 2018 NOC 21392 |
| TEGSEDI Inotersen Sodium |
Akcea Therapeutics Inc | Prescription Pharmaceutical Priority-NAS |
3 Oct 2018 NOC 21389 |
| RADICAVA Edaravone 2 clinical trials → |
Mitsubishi Tanabe Pharma Corporation | Prescription Pharmaceutical Priority-NAS |
3 Oct 2018 NOC 21386 |
| VELTASSA Patiromer Sorbitex Calcium |
Vifor Fresenius Medical Care Renal Pharma Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
3 Oct 2018 NOC 21384 |
| TAKHZYRO Lanadelumab |
Shire Pharma Canada Ulc | Biologic Priority-NAS |
19 Sep 2018 NOC 21320 |
| FETZIMA Levomilnacipran |
Allergan Inc | Prescription Pharmaceutical Labelling Only |
14 Sep 2018 NOC 21316 |
| CABOMETYX Cabozantinib 47 clinical trials → |
Ipsen Biopharmaceuticals Canada Inc | Prescription Pharmaceutical Priority-NAS |
14 Sep 2018 NOC 21309 |
| STROMECTOL Ivermectin 3 clinical trials → |
Merck Canada Inc | Prescription Pharmaceutical Other |
5 Sep 2018 NOC 21282 |
| KYMRIAH Tisagenlecleucel 5 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Biologic Priority-NAS |
5 Sep 2018 NOC 21274 |
| KYMRIAH Tisagenlecleucel 5 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Biologic Priority |
5 Sep 2018 NOC 21273 |
| XYDALBA Dalbavancin |
Cipher Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS |
4 Sep 2018 NOC 21279 |
| COSMEGEN Dactinomycin 7 clinical trials → |
Recordati Rare Diseases Canada Inc | Prescription Pharmaceutical Labelling Only |
29 Aug 2018 NOC 21259 |
| CONSTELLA Linaclotide |
Allergan Inc | Prescription Pharmaceutical Labelling Only |
28 Aug 2018 NOC 21249 |
| PMS-PROGESTERONE Progesterone 9 clinical trials → |
Pharmascience Inc | Prescription Pharmaceutical Other |
22 Aug 2018 NOC 21236 |
| OLUMIANT Baricitinib 28 clinical trials → |
Eli Lilly Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
17 Aug 2018 NOC 21225 |
| NUCEIVA Prabotulinumtoxina |
Evolus Incorporated | Biologic Other |
16 Aug 2018 NOC 21217 |
| PERINDOPRIL ERBUMINE / INDAPAMIDE, PERINDOPRIL ERBUMINE / INDAPAMIDE HD Perindopril Erbumine, Indapamide |
Sivem Pharmaceuticals Ulc | Prescription Pharmaceutical Labelling Only |
10 Aug 2018 NOC 21195 |
| PERINDOPRIL ERBUMINE Perindopril Erbumine |
Sivem Pharmaceuticals Ulc | Prescription Pharmaceutical Labelling Only |
3 Aug 2018 NOC 21179 |
| HEMLIBRA Emicizumab 6 clinical trials → |
Hoffmann La Roche Limited | Biologic Priority-NAS |
2 Aug 2018 NOC 21170 |
| AIMOVIG Erenumab |
Novartis Pharmaceuticals Canada Inc | Biologic New Active Substance (NAS) |
1 Aug 2018 NOC 21166 |
| SANDOZ FLUOXETINE Fluoxetine Hydrochloride 10 clinical trials → |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
30 Jul 2018 NOC 21159 |
| ALUNBRIG Brigatinib 9 clinical trials → |
Takeda Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
26 Jul 2018 NOC 21145 |
| PANHEMATIN Hemin |
Recordati Rare Diseases Canada Inc | Biologic Priority-NAS |
13 Jul 2018 NOC 21075 |
| NITRO-DUR 0.2, NITRO-DUR 0.4, NITRO-DUR 0.6, NITRO-DUR 0.8 Nitroglycerin 6 clinical trials → |
Uspharma Ltd | Nonprescription Pharmaceutical Labelling Only |
12 Jul 2018 NOC 21078 |
| BIKTARVY Emtricitabine, Bictegravir Sodium, Tenofovir Alafenamide Hemifumarate |
Gilead Sciences Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
10 Jul 2018 NOC 21065 |
| RAYALDEE Calcifediol |
Vifor Fresenius Medical Care Renal Pharma Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
10 Jul 2018 NOC 21063 |
| SOLIQUA Insulin Glargine, Lixisenatide |
Sanofi-aventis Canada Inc | Prescription Pharmaceutical Other |
6 Jul 2018 NOC 21058 |
| ERLEADA Apalutamide 30 clinical trials → |
Janssen Inc | Prescription Pharmaceutical Priority-NAS |
3 Jul 2018 NOC 21043 |
| SYMDEKO Ivacaftor, Tezacaftor |
Vertex Pharmaceuticals (canada) Incorporated | Prescription Pharmaceutical Priority-NAS |
27 Jun 2018 NOC 22554 |
| MONOFERRIC Iron Isomaltoside 1000 |
Pharmacosmos A/s | Prescription Pharmaceutical New Active Substance (NAS) |
22 Jun 2018 NOC 21007 |
| FLUOXETINE Fluoxetine Hydrochloride 10 clinical trials → |
Sivem Pharmaceuticals Ulc | Prescription Pharmaceutical Labelling Only |
13 Jun 2018 NOC 20983 |
| DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP Doxorubicin Hydrochloride 126 clinical trials → |
Pfizer Canada Inc | Prescription Pharmaceutical Labelling Only |
8 Jun 2018 NOC 20966 |
| EUCRISA Crisaborole |
Pfizer Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
7 Jun 2018 NOC 20950 |
| RESTASIS MULTIDOSE Cyclosporine 13 clinical trials → |
Allergan Inc | Prescription Pharmaceutical Other |
1 Jun 2018 NOC 20929 |
| SEGLUROMET Metformin Hydrochloride, Ertugliflozin |
Merck Canada Inc | Prescription Pharmaceutical Other |
30 May 2018 NOC 20912 |
| STEGLUJAN Sitagliptin Phosphate Monohydrate, Ertugliflozin |
Merck Canada Inc | Prescription Pharmaceutical Other |
22 May 2018 NOC 20884 |
| JULUCA Rilpivirine Hydrochloride, Dolutegravir Sodium |
Viiv Healthcare Ulc | Prescription Pharmaceutical Other |
18 May 2018 NOC 20876 |
| ALPHANATE Antihemophilic Factor (human), Von Willebrand Factor (human) |
Grifols Biologicals Llc | Biologic Other |
11 May 2018 NOC 20854 |
| PLAN B Levonorgestrel 2 clinical trials → |
Foundation Consumer Healthcare, Llc | Nonprescription Pharmaceutical Labelling Only |
9 May 2018 NOC 20858 |
| STEGLATRO Ertugliflozin 2 clinical trials → |
Merck Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
9 May 2018 NOC 20842 |
| HADLIMA, HADLIMA PUSHTOUCH Adalimumab 35 clinical trials → |
Samsung Bioepis Co., Ltd | Prescription Pharmaceutical Other |
8 May 2018 NOC 20841 |
| HADLIMA, HADLIMA PUSHTOUCH Adalimumab 35 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
8 May 2018 NOC 20840 |
| IMFINZI Durvalumab 214 clinical trials → |
Astrazeneca Canada Inc | Biologic Other · with conditions |
4 May 2018 NOC 20824 |
| BAVENCIO Avelumab 31 clinical trials → |
Emd Serono A Division Of Emd Inc Canada | Biologic Other · with conditions |
4 May 2018 NOC 20823 |
| MVASI Bevacizumab 400 clinical trials → |
Amgen Canada Inc | Biologic Other |
30 Apr 2018 NOC 20799 |
| DANTRIUM CAPSULES Dantrolene Sodium |
Endo Par Innovation Company, Llc | Prescription Pharmaceutical Labelling Only |
26 Apr 2018 NOC 20803 |
| DANTRIUM INTRAVENOUS Dantrolene Sodium |
Endo Par Innovation Company, Llc | Prescription Pharmaceutical Labelling Only |
24 Apr 2018 NOC 20785 |
| PROBUPHINE Buprenorphine Hydrochloride 5 clinical trials → |
Knight Therapeutics Inc. | Prescription Pharmaceutical Other |
18 Apr 2018 NOC 20748 |
| FUCIBET Betamethasone, Fusidic Acid |
Leo Pharma Inc | Prescription Pharmaceutical Other |
12 Apr 2018 NOC 20730 |
| XULTOPHY Liraglutide, Insulin Degludec |
Novo Nordisk Canada Inc | Biologic Other |
11 Apr 2018 NOC 20731 |
| CYSTADANE Betaine |
Recordati Rare Diseases Canada Inc | Prescription Pharmaceutical Labelling Only |
11 Apr 2018 NOC 20729 |
| BIO ASSURE Hydrogen Peroxide, Peracetic Acid |
Wood Wyant Inc | Nonprescription Pharmaceutical Other |
11 Apr 2018 NOC 20727 |
| PENTHROX Methoxyflurane 3 clinical trials → |
Purdue Pharma | Prescription Pharmaceutical Other |
7 Apr 2018 NOC 20719 |
| ARBESDA RESPICLICK Fluticasone Propionate, Salmeterol Xinafoate |
Teva Canada Limited | Prescription Pharmaceutical Other |
6 Apr 2018 NOC 20712 |
| LAPELGA Pegfilgrastim 18 clinical trials → |
Apotex Inc | Biologic Other |
5 Apr 2018 NOC 20695 |
| DEXTROAMPHETAMINE Dextroamphetamine Sulfate |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
4 Apr 2018 NOC 20692 |
| TRELEGY ELLIPTA Fluticasone Furoate, Umeclidinium Bromide, Vilanterol Trifenatate |
Glaxosmithkline Inc | Prescription Pharmaceutical Other |
4 Apr 2018 NOC 20690 |
| REKOVELLE Follitropin Delta 3 clinical trials → |
Ferring Inc | Biologic New Active Substance (NAS) |
22 Mar 2018 NOC 20653 |
| MEZERA Mesalazine 4 clinical trials → |
Avir Pharma Inc | Prescription Pharmaceutical Other |
20 Mar 2018 NOC 20646 |
| BESPONSA Inotuzumab Ozogamicin 13 clinical trials → |
Pfizer Canada Inc | Biologic New Active Substance (NAS) |
15 Mar 2018 NOC 20620 |
| MAR-CIDOFOVIR Cidofovir |
Marcan Pharmaceuticals Inc | Prescription Pharmaceutical Other |
14 Mar 2018 NOC 20624 |
| APO-PERINDOPRIL ARGININE Perindopril Arginine |
Apotex Inc | Prescription Pharmaceutical Other |
9 Mar 2018 NOC 20598 |
| SYMTUZA Emtricitabine, Darunavir Ethanolate, Cobicistat, Tenofovir Alafenamide Hemifumarate |
Janssen Inc | Prescription Pharmaceutical Other |
8 Mar 2018 NOC 20589 |
| MYLAN-PERINDOPRIL ARGININE Perindopril Arginine |
Mylan Pharmaceuticals Ulc | Prescription Pharmaceutical Other |
7 Mar 2018 NOC 20580 |
| RECOTHROM Thrombin Alfa |
Mallinckrodt Hospital Products Inc | Biologic Labelling Only |
6 Mar 2018 NOC 20648 |
| SILIQ Brodalumab 3 clinical trials → |
Valeant Canada Lp Valeant Canada S.e.c. | Biologic New Active Substance (NAS) |
6 Mar 2018 NOC 20560 |
| BEVESPI AEROSPHERE Formoterol Fumarate Dihydrate, Glycopyrronium Bromide |
Astrazeneca Canada Inc | Prescription Pharmaceutical Other |
5 Mar 2018 NOC 20561 |
| KISQALI Ribociclib Succinate 64 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
2 Mar 2018 NOC 20544 |
| TIMOLOL Timolol Maleate |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
27 Feb 2018 NOC 20534 |
| ADDYI Flibanserin |
Sprout Pharmaceuticals Inc | Prescription Pharmaceutical New Active Substance (NAS) |
27 Feb 2018 NOC 20529 |
| FASENRA Benralizumab 13 clinical trials → |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) |
22 Feb 2018 NOC 20519 |
| AFLURIA TETRA Haemagglutinin-strain A(h1n1), Haemagglutinin-strain A(h3n2), Haemagglutinin-strain B(victoria), Haemagglutinin-strain B(yamagata) |
Seqirus Pty Ltd | Biologic Other |
22 Feb 2018 NOC 20517 |
| CUTAQUIG Immunoglobulin G (human) |
Octapharma Pharmazeutika Produktionsges M B H | Biologic Other |
15 Feb 2018 NOC 20489 |
| OCREVUS Ocrelizumab 24 clinical trials → |
Hoffmann La Roche Limited | Biologic Priority · with conditions |
14 Feb 2018 NOC 20482 |
| CONTRAVE Naltrexone Hydrochloride, Bupropion Hydrochloride |
Valeant Canada Lp Valeant Canada S.e.c. | Prescription Pharmaceutical Other |
13 Feb 2018 NOC 20469 |
| NORFLOXACIN Norfloxacin |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
8 Feb 2018 NOC 20462 |
| LONSURF Trifluridine, Tipiracil Hydrochloride |
Taiho Pharma Canada, Inc. | Prescription Pharmaceutical Priority-NAS |
25 Jan 2018 NOC 20405 |
| DOXEPIN Doxepin Hcl |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
9 Jan 2018 NOC 20291 |
| TEMAZEPAM Temazepam |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
5 Jan 2018 NOC 20266 |
| VELPHORO Sucroferric Oxyhydroxide |
Vifor Fresenius Medical Care Renal Pharma Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
5 Jan 2018 NOC 20264 |
| OZEMPIC Semaglutide 110 clinical trials → |
Novo Nordisk Canada Inc | Biologic New Active Substance (NAS) |
4 Jan 2018 NOC 20302 |
| ENALAPRIL MALEATE/HCTZ Enalapril Maleate, Hydrochlorothiazide |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
28 Dec 2017 NOC 20212 |
| XIIDRA Lifitegrast |
Shire Pharma Canada Ulc | Prescription Pharmaceutical New Active Substance (NAS) |
22 Dec 2017 NOC 20205 |
| AMINOSYN Alanine, Arginine, Glycine, Histidine, Isoleucine, Lysine, Leucine, Methionine |
Icu Medical Canada Inc | Nonprescription Pharmaceutical Labelling Only |
22 Dec 2017 NOC 20201 |
| AMINOSYN II N-acetyl-l-tyrosine, L-alanine, L-aspartic Acid, Glutamic Acid, Glycine, L-arginine, L-histidine Hcl, L-isoleucine |
Icu Medical Canada Inc | Nonprescription Pharmaceutical Labelling Only |
22 Dec 2017 NOC 20200 |
| ZOLADEX, ZOLADEX LA Goserelin Acetate 26 clinical trials → |
Tersera Therapeutics Llc | Prescription Pharmaceutical Labelling Only |
21 Dec 2017 NOC 20186 |
| BAVENCIO Avelumab 31 clinical trials → |
Emd Serono A Division Of Emd Inc Canada | Biologic New Active Substance (NAS) · with conditions |
18 Dec 2017 NOC 20169 |
| KANUMA Sebelipase Alfa |
Alexion Pharma Gmbh | Biologic New Active Substance (NAS) · with conditions |
15 Dec 2017 NOC 20164 |
| SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE, SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE HD, SANDOZ PERINDOPRIL ERBUMINE/INDAPAMIDE LD Perindopril Erbumine, Indapamide |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
12 Dec 2017 NOC 20243 |
| TRIAMCINOLONE HEXACETONIDE INJECTABLE SUSPENSION Triamcinolone Hexacetonide |
Medexus Inc | Prescription Pharmaceutical Other |
12 Dec 2017 NOC 20144 |
| SANDOZ PERINDOPRIL ERBUMINE Perindopril Erbumine |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
7 Dec 2017 NOC 20137 |
| DATSCAN Ioflupane (123i) |
Ge Healthcare Canada Inc | Radiopharmaceutical New Active Substance (NAS) |
7 Dec 2017 NOC 20128 |
| FOQUEST Methylphenidate Hydrochloride 11 clinical trials → |
Purdue Pharma | Prescription Pharmaceutical Other |
6 Dec 2017 NOC 20242 |
| RENFLEXIS Infliximab 39 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
1 Dec 2017 NOC 20122 |
| TICLOPIDINE Ticlopidine Hcl |
Aa Pharma Inc | Prescription Pharmaceutical Labelling Only |
1 Dec 2017 NOC 20113 |
| ABILIFY Aripiprazole 7 clinical trials → |
Otsuka Pharmaceutical Co Ltd | Prescription Pharmaceutical Labelling Only |
1 Dec 2017 NOC 20112 |
| DUPIXENT Dupilumab 57 clinical trials → |
Sanofi-aventis Canada Inc | Biologic New Active Substance (NAS) |
30 Nov 2017 NOC 20101 |
| MAVENCLAD Cladribine 7 clinical trials → |
Emd Serono A Division Of Emd Inc Canada | Prescription Pharmaceutical Other |
30 Nov 2017 NOC 20099 |
| REBINYN Coagulation Factor Ix (recombinant), Pegylated |
Novo Nordisk Canada Inc | Biologic New Active Substance (NAS) |
29 Nov 2017 NOC 20100 |
| SITAVIG Acyclovir 4 clinical trials → |
Cipher Pharmaceuticals Inc | Prescription Pharmaceutical Other |
27 Nov 2017 NOC 20091 |
| LARTRUVO Olaratumab |
Eli Lilly Canada Inc | Biologic New Active Substance (NAS) · with conditions |
23 Nov 2017 NOC 20078 |
| BIODESTROY Hydrogen Peroxide, Peracetic Acid |
Sani-marc Inc | Nonprescription Pharmaceutical Other |
23 Nov 2017 NOC 20068 |
| ADMELOG Insulin Lispro 2 clinical trials → |
Sanofi-aventis Canada Inc | Biologic Other |
16 Nov 2017 NOC 20050 |
| TREMFYA Guselkumab 32 clinical trials → |
Janssen Inc | Biologic New Active Substance (NAS) |
10 Nov 2017 NOC 20044 |
| ANTHRASIL (ANTHRAX IMMUNE GLOBULIN (HUMAN)) Anthrax Immunoglobulin (human) |
Emergent Biosolutions Canada Inc | Biologic New Active Substance (NAS) |
6 Nov 2017 NOC 20008 |
| IMFINZI Durvalumab 214 clinical trials → |
Astrazeneca Canada Inc | Biologic New Active Substance (NAS) · with conditions |
3 Nov 2017 NOC 20026 |
| CARNITOR Levocarnitine, L-carnitine Hcl |
Leadiant Biosciences, Inc. | Prescription Pharmaceutical Labelling Only |
2 Nov 2017 NOC 19995 |
| PREVYMIS Letermovir 9 clinical trials → |
Merck Canada Inc | Prescription Pharmaceutical Priority-NAS |
1 Nov 2017 NOC 19991 |
| BACA RESPICLICK Salbutamol Sulfate 4 clinical trials → |
Teva Canada Limited | Prescription Pharmaceutical Other |
1 Nov 2017 NOC 19988 |
| CUVPOSA Glycopyrrolate |
Pediapharm Inc | Prescription Pharmaceutical Other |
30 Oct 2017 NOC 19979 |
| SHINGRIX Varicella-zoster Virus Glycoprotein E (ge) |
Glaxosmithkline Inc | Biologic New Active Substance (NAS) |
13 Oct 2017 NOC 19911 |
| ACCEL-SEVELAMER Sevelamer Carbonate |
Accel Pharma Inc | Prescription Pharmaceutical Other |
11 Oct 2017 NOC 19901 |
| AURO-CEFIXIME Cefixime |
Auro Pharma Inc | Prescription Pharmaceutical Other |
11 Oct 2017 NOC 19900 |
| TRUMENBA Neisseria Meningitidis Grp B Recombinant Lipoprotein 2086 Subfamily A, Neisseria Meningitidis Grp B Recombinant Lipoprotein 2086 Subfamily B |
Pfizer Canada Inc | Biologic New Active Substance (NAS) |
5 Oct 2017 NOC 19881 |
| APO-KETOROLAC Ketorolac Tromethamine |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
4 Oct 2017 NOC 19885 |
| XENICAL Orlistat 3 clinical trials → |
Cheplapharm Arzneimittel Gmbh Germany | Prescription Pharmaceutical Labelling Only |
28 Sep 2017 NOC 19862 |
| AKYNZEO Palonosetron Hydrochloride, Netupitant |
Purdue Pharma | Prescription Pharmaceutical New Active Substance (NAS) |
28 Sep 2017 NOC 19860 |
| DYMISTA Fluticasone Propionate, Azelastine Hydrochloride |
Bgp Pharma Ulc | Prescription Pharmaceutical Labelling Only |
12 Sep 2017 NOC 19795 |
| GALAFOLD Migalastat Hydrochloride 3 clinical trials → |
Amicus Therapeutics Uk Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
5 Sep 2017 NOC 19758 |
| HAEGARDA C1 Esterase Inhibitor (human) |
Csl Behring Canada Inc | Biologic Other |
1 Sep 2017 NOC 19746 |
| TRESIBA (FLEXTOUCH), TRESIBA (PENFILL) Insulin Degludec 6 clinical trials → |
Novo Nordisk Canada Inc | Biologic New Active Substance (NAS) |
25 Aug 2017 NOC 19717 |
| AERMONY RESPICLICK Fluticasone Propionate 2 clinical trials → |
Teva Canada Limited | Prescription Pharmaceutical Other |
22 Aug 2017 NOC 19697 |
| ADVIL HEADACHE & MIGRAINE CAPLETS, ADVIL HEADACHE & MIGRAINE EXTRA STRENGTH, ADVIL HEADACHE & MIGRAINE TABLETS Ibuprofen Sodium Dihydrate 22 clinical trials → |
Pfizer Consumer Healthcare A Division Of Pfizer Canada Inc | Nonprescription Pharmaceutical Labelling Only |
22 Aug 2017 NOC 19692 |
| ADVIL MIGRAINE CAPLETS, ADVIL MIGRAINE EXTRA STRENGTH, ADVIL MIGRAINE TABLETS Ibuprofen Sodium Dihydrate 22 clinical trials → |
Pfizer Consumer Healthcare A Division Of Pfizer Canada Inc | Nonprescription Pharmaceutical Labelling Only |
22 Aug 2017 NOC 19691 |
| ADVIL HEADACHE CAPLETS, ADVIL HEADACHE EXTRA STRENGTH, ADVIL HEADACHE TABLETS Ibuprofen Sodium Dihydrate 22 clinical trials → |
Pfizer Consumer Healthcare A Division Of Pfizer Canada Inc | Nonprescription Pharmaceutical Labelling Only |
22 Aug 2017 NOC 19690 |
| REACTINE RAPID DISSOLVE Cetirizine Hydrochloride |
Mcneil Consumer Healthcare Division Of Johnson & Johnson Inc | Nonprescription Pharmaceutical Labelling Only |
18 Aug 2017 NOC 19679 |
| FLEBOGAMMA 10%, FLEBOGAMMA 5% Immunoglobulin (human) |
Instituto Grifols S.a. | Biologic Other |
17 Aug 2017 NOC 19664 |
| VOSEVI Sofosbuvir, Velpatasvir, Voxilaprevir |
Gilead Sciences Canada Inc | Prescription Pharmaceutical Priority-NAS |
16 Aug 2017 NOC 19660 |
| MAVIRET Glecaprevir, Pibrentasvir |
Abbvie Corporation | Prescription Pharmaceutical Priority-NAS |
16 Aug 2017 NOC 19659 |
| OCREVUS Ocrelizumab 24 clinical trials → |
Hoffmann La Roche Limited | Biologic New Active Substance (NAS) |
14 Aug 2017 NOC 19940 |
| ONIVYDE Irinotecan Hydrochloride Trihydrate 140 clinical trials → |
Baxalta Canada Corporation | Prescription Pharmaceutical Priority |
9 Aug 2017 NOC 19642 |
| APO-DESVENLAFAXINE Desvenlafaxine 2 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Other |
8 Aug 2017 NOC 19640 |
| ACTONEL, ACTONEL DR Risedronate Sodium Hemi-pentahydrate |
Allergan Pharma Co. | Prescription Pharmaceutical Labelling Only |
3 Aug 2017 NOC 19621 |
| SANDOZ OXCARBAZEPINE Oxcarbazepine |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
2 Aug 2017 NOC 19616 |
| ENTUZITY KWIKPEN Insulin Injection Human Biosynthetic |
Eli Lilly Canada Inc | Biologic Other |
27 Jul 2017 NOC 19590 |
| RYDAPT Midostaurin 5 clinical trials → |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical Priority-NAS |
21 Jul 2017 NOC 19563 |
| LIPIODOL ULTRA FLUID Iodine |
Guerbet | Prescription Pharmaceutical Other |
13 Jul 2017 NOC 19537 |
| LOLO Ethinyl Estradiol, Norethindrone Acetate |
Allergan Pharma Co. | Prescription Pharmaceutical Labelling Only |
11 Jul 2017 NOC 19518 |
| MACROBID Nitrofurantoin 4 clinical trials → |
Allergan Pharma Co. | Prescription Pharmaceutical Labelling Only |
10 Jul 2017 NOC 19517 |
| DEFITELIO Defibrotide |
Jazz Pharmaceuticals Ireland Limited | Biologic Priority-NAS |
10 Jul 2017 NOC 19515 |
| SPINRAZA Nusinersen Sodium 3 clinical trials → |
Biogen Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
29 Jun 2017 NOC 19476 |
| APO-FLUOXETINE Fluoxetine Hydrochloride 10 clinical trials → |
Apotex Inc | Prescription Pharmaceutical Labelling Only |
23 Jun 2017 NOC 19467 |
| VOLTAREN EMULGEL JOINT PAIN EXTRA STRENGTH Diclofenac Diethylamine |
Glaxosmithkline Consumer Healthcare Inc | Nonprescription Pharmaceutical Labelling Only |
23 Jun 2017 NOC 19459 |
| VOLTAREN EMULGEL BACK & MUSCLE PAIN Diclofenac Diethylamine |
Glaxosmithkline Consumer Healthcare Inc | Nonprescription Pharmaceutical Labelling Only |
23 Jun 2017 NOC 19453 |
| BELBUCA Buprenorphine Hydrochloride 5 clinical trials → |
Paladin Labs Inc | Prescription Pharmaceutical Other |
21 Jun 2017 NOC 19443 |
| PMS-FLUOXETINE Fluoxetine Hydrochloride 10 clinical trials → |
Pharmascience Inc | Prescription Pharmaceutical Other |
13 Jun 2017 NOC 19409 |
| PROCYSBI Cysteamine Bitartrate |
Horizon Pharma Ireland Ltd | Prescription Pharmaceutical Priority-NAS |
13 Jun 2017 NOC 19408 |
| FIBRYNA Fibrinogen (human) |
Octapharma Pharmazeutika Produktionsges M B H | Biologic Other |
7 Jun 2017 NOC 19383 |
| ADLYXINE Lixisenatide |
Sanofi-aventis Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
25 May 2017 NOC 19339 |
| OCALIVA Obeticholic Acid |
Intercept Pharmaceuticals Inc | Prescription Pharmaceutical Priority-NAS · with conditions |
24 May 2017 NOC 19342 |
| T-LO, TIMOLOL MALEATE-EX Timolol Maleate |
Sandoz Canada Incorporated | Prescription Pharmaceutical Labelling Only |
19 May 2017 NOC 19326 |
| VEMLIDY Tenofovir Alafenamide Hemifumarate |
Gilead Sciences Canada Inc | Prescription Pharmaceutical Other |
17 May 2017 NOC 19317 |
| ACARIZAX Dermatophagoides Farinae Extract, Dermatophagoides Pteronyssinus Extract |
Alk Abello A/s | Biologic Other |
4 May 2017 NOC 19253 |
| OZANEX (OZENOXACIN) Ozenoxacin |
Ferrer Internacional Sa | Prescription Pharmaceutical New Active Substance (NAS) |
1 May 2017 NOC 19219 |
| CERDELGA Eliglustat Tartrate 2 clinical trials → |
Sanofi Genzyme, A Division Of Sanofi-aventis Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
21 Apr 2017 NOC 19194 |
| TECENTRIQ Atezolizumab 173 clinical trials → |
Hoffmann La Roche Limited | Biologic New Active Substance (NAS) · with conditions |
12 Apr 2017 NOC 19156 |
| ERELZI (SYRINGE), ERELZI (SENSOREADY PEN) Etanercept 11 clinical trials → |
Sandoz Canada Incorporated | Biologic Other |
6 Apr 2017 NOC 19131 |
| UTROGESTAN Progesterone 9 clinical trials → |
Besins Healthcare S A | Prescription Pharmaceutical Other |
5 Apr 2017 NOC 19123 |
| WAYMADE-KETOROLAC TROMETHAMINE Ketorolac Tromethamine |
Waymade Plc | Prescription Pharmaceutical Labelling Only |
3 Apr 2017 NOC 19121 |
| TEPADINA Thiotepa 11 clinical trials → |
Adienne Sa | Prescription Pharmaceutical Other · with conditions |
29 Mar 2017 NOC 19108 |
| PORTRAZZA Necitumumab 2 clinical trials → |
Eli Lilly Canada Inc | Biologic New Active Substance (NAS) |
16 Mar 2017 NOC 19071 |
| BRINAVESS Vernakalant Hydrochloride |
Cardiome Uk Limited | Prescription Pharmaceutical New Active Substance (NAS) |
13 Mar 2017 NOC 19050 |
| NUCYNTA EXTENDED-RELEASE Tapentadol Hydrochloride |
Endo Ventures Ltd | Prescription Pharmaceutical Labelling Only |
3 Mar 2017 NOC 19021 |
| ONCASPAR Pegaspargase 13 clinical trials → |
Baxalta Canada Corporation | Biologic Other |
24 Feb 2017 NOC 19033 |
| NEURACEQ Florbetaben (18f) |
Isologic Innovative Radiopharmaceuticals Ltd. | Radiopharmaceutical New Active Substance (NAS) |
22 Feb 2017 NOC 18999 |
| REXULTI Brexpiprazole 3 clinical trials → |
Otsuka Pharmaceutical Co Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
16 Feb 2017 NOC 18987 |
| CUVITRU Immunoglobulin (human) |
Baxalta Canada Corporation | Biologic Other |
16 Feb 2017 NOC 18976 |
| NUCYNTA IR Tapentadol Hydrochloride |
Endo Ventures Ltd | Prescription Pharmaceutical Labelling Only |
13 Feb 2017 NOC 18960 |
| ODEFSEY Emtricitabine, Rilpivirine Hydrochloride, Tenofovir Alafenamide Fumarate |
Gilead Sciences Canada Inc | Prescription Pharmaceutical Other |
10 Feb 2017 NOC 18956 |
| REPLAGAL Agalsidase Alfa |
Shire Human Genetic Therapies Inc | Biologic Other · with conditions |
10 Feb 2017 NOC 18950 |
| APO-ASA LD Acetylsalicylic Acid 15 clinical trials → |
Apotex Inc | Nonprescription Pharmaceutical Labelling Only |
9 Feb 2017 NOC 18955 |
| VIBERZI Eluxadoline |
Allergan Pharma Co. | Prescription Pharmaceutical New Active Substance (NAS) |
26 Jan 2017 NOC 18907 |
| BAR-HYDROMORPHONE HCL Hydromorphone Hcl 2 clinical trials → |
Bard Pharmaceuticals (1990) Inc | Prescription Pharmaceutical Labelling Only |
20 Jan 2017 NOC 18898 |
| DAXAS Roflumilast 8 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical Labelling Only |
20 Jan 2017 NOC 18895 |
| OMNARIS Ciclesonide |
Astrazeneca Canada Inc | Prescription Pharmaceutical Labelling Only |
20 Jan 2017 NOC 18894 |
| ALVESCO Ciclesonide |
Astrazeneca Canada Inc | Prescription Pharmaceutical Labelling Only |
20 Jan 2017 NOC 18893 |
| LIXIANA Edoxaban 17 clinical trials → |
Servier Canada Inc | Prescription Pharmaceutical Labelling Only |
17 Jan 2017 NOC 18879 |
| GLATECT Glatiramer Acetate |
Pharmascience Inc | Prescription Pharmaceutical Other |
17 Jan 2017 NOC 18876 |
| KEVZARA Sarilumab 9 clinical trials → |
Sanofi-aventis Canada Inc | Biologic New Active Substance (NAS) |
12 Jan 2017 NOC 18855 |
| FIASP Insulin Aspart 3 clinical trials → |
Novo Nordisk Canada Inc | Biologic Other |
6 Jan 2017 NOC 18839 |
| MICTORYL, MICTORYL PEDIATRIC Propiverine Hydrochloride 2 clinical trials → |
Duchesnay Inc | Prescription Pharmaceutical New Active Substance (NAS) |
5 Jan 2017 NOC 36407 |
| RAPIVAB Peramivir 2 clinical trials → |
Biocryst Pharmaceuticals Inc | Prescription Pharmaceutical New Active Substance (NAS) |
5 Jan 2017 NOC 18829 |
| HAIR REGROWTH TREATMENT Minoxidil 12 clinical trials → |
Apotex Inc | Nonprescription Pharmaceutical Labelling Only |
23 Dec 2016 NOC 18818 |
| LANCORA Ivabradine Hydrochloride 4 clinical trials → |
Servier Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
23 Dec 2016 NOC 18815 |
| REVESTIVE Teduglutide 2 clinical trials → |
Shire Pharmaceuticals Ireland Limited | Biologic Labelling Only |
22 Dec 2016 NOC 18809 |
| GLYXAMBI Linagliptin, Empagliflozin |
Boehringer Ingelheim (canada) Ltd Ltee | Prescription Pharmaceutical Other |
15 Dec 2016 NOC 18771 |
| ORFADIN Nitisinone |
Swedish Orphan Biovitrum Ab (publ) | Prescription Pharmaceutical Priority-NAS |
13 Dec 2016 NOC 18759 |
| KYLEENA Levonorgestrel 2 clinical trials → |
Bayer Inc | Prescription Pharmaceutical Other |
13 Dec 2016 NOC 18758 |
| AFSTYLA Lonoctocog Alfa |
Csl Behring Canada Inc | Biologic New Active Substance (NAS) |
12 Dec 2016 NOC 18755 |
| OTIXAL Ciprofloxacin Hydrochloride, Fluocinolone Acetonide |
Pediapharm Inc | Prescription Pharmaceutical Other |
8 Dec 2016 NOC 18739 |
| BAT Botulinum Antitoxin Serotype A, Botulinum Antitoxin Serotype B, Botulinum Antitoxin Serotype C, Botulinum Antitoxin Serotype D, Botulinum Antitoxin Serotype E, Botulinum Antitoxin Serotype F, Botulinum Antitoxin Serotype G |
Cangene Corporation | Biologic New Active Substance (NAS) |
8 Dec 2016 NOC 18737 |
| ZINBRYTA Daclizumab Beta |
Biogen Canada Inc | Biologic New Active Substance (NAS) |
8 Dec 2016 NOC 18736 |
| DOTAREM Gadoterate Meglumine 2 clinical trials → |
Guerbet | Nonprescription Pharmaceutical New Active Substance (NAS) |
25 Nov 2016 NOC 18694 |
| KYPROLIS Carfilzomib 46 clinical trials → |
Amgen Canada Inc | Prescription Pharmaceutical Other |
22 Nov 2016 NOC 18689 |
| MOVAPO Apomorphine Hcl |
Paladin Labs Inc | Prescription Pharmaceutical Other |
22 Nov 2016 NOC 18685 |
| QTERN Dapagliflozin, Saxagliptin |
Astrazeneca Canada Inc | Prescription Pharmaceutical Other |
22 Nov 2016 NOC 18684 |
| ADYNOVATE Antihemophilic Factor (recombinant), Pegylated |
Baxalta Canada Corporation | Biologic New Active Substance (NAS) |
17 Nov 2016 NOC 18666 |
| AA-CLOZAPINE Clozapine 8 clinical trials → |
Aa Pharma Inc | Prescription Pharmaceutical Other |
8 Nov 2016 NOC 18648 |
| NITISINONE TABLETS Nitisinone |
Cycle Pharmaceuticals Ltd | Prescription Pharmaceutical Priority-NAS |
4 Nov 2016 NOC 18637 |
| LIXIANA Edoxaban 17 clinical trials → |
Daiichi Sankyo Inc | Prescription Pharmaceutical New Active Substance (NAS) |
4 Nov 2016 NOC 18635 |
| PAZEO Olopatadine Hcl |
Alcon Canada Inc | Prescription Pharmaceutical Other |
28 Oct 2016 NOC 18612 |
| REOPRO Abciximab |
Janssen Inc | Biologic Labelling Only |
13 Oct 2016 NOC 18564 |
| NALOXONE HYDROCHLORIDE NASAL SPRAY Naloxone Hydrochloride 2 clinical trials → |
Adapt Pharma Operations Limited | Nonprescription Pharmaceutical Other |
3 Oct 2016 NOC 18531 |
| VENCLEXTA Venetoclax 204 clinical trials → |
Abbvie Corporation | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
30 Sep 2016 NOC 18536 |
| ALECENSARO Alectinib Hydrochloride 24 clinical trials → |
Hoffmann La Roche Limited | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
29 Sep 2016 NOC 18535 |
| NIGHTTIME COLD, COUGH AND FLU Diphenhydramine Hcl, Ibuprofen |
Apotex Inc | Nonprescription Pharmaceutical Labelling Only |
23 Sep 2016 NOC 18518 |
| IZBA Travoprost |
Alcon Canada Inc | Prescription Pharmaceutical Other |
23 Sep 2016 NOC 18510 |
| HEMANGIOL Propranolol Hydrochloride 21 clinical trials → |
Pierre Fabre Dermo-cosmetique Canada Inc | Prescription Pharmaceutical Other |
23 Sep 2016 NOC 18505 |
| ZEMAIRA Alpha1-proteinase Inhibitor (human) |
Csl Behring Canada Inc | Biologic Other |
21 Sep 2016 NOC 18497 |
| MDK-NITISINONE Nitisinone |
Mendelikabs Inc | Prescription Pharmaceutical Priority-NAS |
20 Sep 2016 NOC 18498 |
| ENSTILAR Betamethasone Dipropionate, Calcipotriol Monohydrate |
Leo Pharma Inc | Prescription Pharmaceutical Other |
13 Sep 2016 NOC 18473 |
| BRENZYS (PFS), BRENZYS (PEN) Etanercept 11 clinical trials → |
Samsung Bioepis Co., Ltd | Biologic Other |
31 Aug 2016 NOC 18480 |
| FLONASE ALLERGY RELIEF Fluticasone Propionate 2 clinical trials → |
Glaxosmithkline Consumer Healthcare Inc | Nonprescription Pharmaceutical Other |
26 Aug 2016 NOC 18447 |
| GENTAMICIN INJECTION USP Gentamicin Sulfate 6 clinical trials → |
Teligent Ou | Prescription Pharmaceutical Other |
19 Aug 2016 NOC 18393 |
| ADVIL 12 HOUR Ibuprofen 22 clinical trials → |
Pfizer Consumer Healthcare A Division Of Pfizer Canada Inc | Nonprescription Pharmaceutical Other |
5 Aug 2016 NOC 18379 |
| ADVIL HEADACHE & MIGRAINE PAIN CAPLETS, ADVIL HEADACHE & MIGRAINE PAIN EXTRA STRENGTH CAPLETS, ADVIL HEADACHE & MIGRAINE PAIN TABLETS Ibuprofen, Ibuprofen Sodium Dihydrate |
Pfizer Consumer Healthcare A Division Of Pfizer Canada Inc | Nonprescription Pharmaceutical Other |
4 Aug 2016 NOC 18598 |
| NEXIUM 24HR Esomeprazole 15 clinical trials → |
Pfizer Consumer Healthcare A Division Of Pfizer Canada Inc | Nonprescription Pharmaceutical Other |
4 Aug 2016 NOC 18378 |
| NINLARO Ixazomib Citrate 6 clinical trials → |
Takeda Canada Inc | Prescription Pharmaceutical Priority-NAS |
4 Aug 2016 NOC 18334 |
| SYNJARDY Metformin Hydrochloride, Empagliflozin |
Boehringer Ingelheim (canada) Ltd Ltee | Prescription Pharmaceutical Other |
29 Jul 2016 NOC 18311 |
| BEPREVE Bepotastine Besilate |
Bausch & Lomb Inc | Prescription Pharmaceutical New Active Substance (NAS) |
27 Jul 2016 NOC 18309 |
| RUPATADINE Rupatadine Fumarate 3 clinical trials → |
Pediapharm Inc | Prescription Pharmaceutical New Active Substance (NAS) |
20 Jul 2016 NOC 18290 |
| CINQAIR Reslizumab |
Teva Canada Limited | Biologic New Active Substance (NAS) |
20 Jul 2016 NOC 18289 |
| EPCLUSA Sofosbuvir, Velpatasvir |
Gilead Sciences Canada Inc | Prescription Pharmaceutical Priority-NAS |
11 Jul 2016 NOC 18265 |
| MONOPROST Latanoprost |
Laboratoires Thea | Prescription Pharmaceutical Other |
7 Jul 2016 NOC 18236 |
| TAGRISSO Osimertinib Mesylate, Osimertinib |
Astrazeneca Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
5 Jul 2016 NOC 18223 |
| SMOFKABIVEN PERIPHERAL L-alanine, Dextrose, Fish Oil, Glycine, L-arginine, L-histidine Hcl, L-isoleucine, L-leucine Hcl |
Fresenius Kabi Canada Ltd | Nonprescription Pharmaceutical Other |
5 Jul 2016 NOC 18221 |
| DARZALEX Daratumumab 98 clinical trials → |
Janssen Inc | Biologic New Active Substance (NAS) · with conditions |
29 Jun 2016 NOC 18215 |
| PANZYGA Immunoglobulin (human) |
Octapharma Pharmazeutika Produktionsges M B H | Biologic Other |
24 Jun 2016 NOC 18206 |
| SYNACTHEN DEPOT Tetracosactide |
Mallinckrodt Specialty Pharmaceuticals Ireland Ltd | Prescription Pharmaceutical Labelling Only |
22 Jun 2016 NOC 18203 |
| EMPLICITI Elotuzumab 11 clinical trials → |
Bristol-myers Squibb Canada | Biologic Priority-NAS |
21 Jun 2016 NOC 18195 |
| CORTIMENT Budesonide 11 clinical trials → |
Ferring Inc | Prescription Pharmaceutical Other |
20 Jun 2016 NOC 18194 |
| INVOKAMET Metformin Hydrochloride, Canagliflozin |
Janssen Inc | Prescription Pharmaceutical Other |
1 Jun 2016 NOC 18144 |
| APO-ZIDOVUDINE-LAMIVUDINE-NEVIRAPINE Zidovudine, Lamivudine, Nevirapine |
Apotex Incorporated | Prescription Pharmaceutical Other |
30 May 2016 NOC 18156 |
| TALTZ Ixekizumab 6 clinical trials → |
Eli Lilly Canada Inc | Biologic New Active Substance (NAS) |
25 May 2016 NOC 18129 |
| MOTRIMAX 12 HOUR BACK & BODY Naproxen, Naproxen Sodium |
Mcneil Consumer Healthcare Division Of Johnson & Johnson Inc | Nonprescription Pharmaceutical Labelling Only |
19 May 2016 NOC 18596 |
| METOJECT SUBCUTANEOUS Methotrexate Sodium 97 clinical trials → |
Medexus Inc | Prescription Pharmaceutical Other |
17 May 2016 NOC 18099 |
| ZONTIVITY Vorapaxar Sulfate |
Merck Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
13 May 2016 NOC 18100 |
| DESCOVY Emtricitabine, Tenofovir Alafenamide Fumarate |
Gilead Sciences Canada Inc | Prescription Pharmaceutical Other |
29 Apr 2016 NOC 18039 |
| OPDIVO (NIVOLUMAB) Nivolumab 268 clinical trials → |
Bristol-myers Squibb Canada | Biologic Other · with conditions |
29 Apr 2016 NOC 18038 |
| LYNPARZA Olaparib 113 clinical trials → |
Astrazeneca Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
29 Apr 2016 NOC 18037 |
| PRAXBIND Idarucizumab |
Boehringer Ingelheim (canada) Ltd Ltee | Biologic New Active Substance (NAS) · with conditions |
29 Apr 2016 NOC 18036 |
| EDARBYCLOR Chlorthalidone, Azilsartan Medoxomil |
Valeant Canada Lp Valeant Canada S.e.c. | Prescription Pharmaceutical Labelling Only |
22 Apr 2016 NOC 18021 |
| BLEXTEN Bilastine |
Aralez Pharmaceuticals Trading Dac | Prescription Pharmaceutical New Active Substance (NAS) |
21 Apr 2016 NOC 18011 |
| BAR-MORPHINE SR Morphine Sulfate 42 clinical trials → |
Bard Pharmaceuticals (1990) Inc | Prescription Pharmaceutical Labelling Only |
12 Apr 2016 NOC 17982 |
| PRALUENT (PFS), PRALUENT (PFP) Alirocumab 8 clinical trials → |
Sanofi-aventis Canada Inc | Biologic New Active Substance (NAS) |
11 Apr 2016 NOC 17976 |
| VITAMIN A (200,000 IU) AND VITAMIN E (40 IU) ORAL LIQUID PREPARATION Vitamin A, Vitamin E |
Nutricorp International | Prescription Pharmaceutical Other |
6 Apr 2016 NOC 17972 |
| VITAMIN A (100,000 IU) AND VITAMIN E (20 IU) ORAL LIQUID PREPARATION Vitamin A, Vitamin E |
Nutricorp International | Prescription Pharmaceutical Other |
6 Apr 2016 NOC 17971 |
| DIARRHEA RELIEF Loperamide Hcl 3 clinical trials → |
Laboratoire Riva Inc | Nonprescription Pharmaceutical Labelling Only |
4 Apr 2016 NOC 17952 |
| S.O.S. NALOXONE HYDROCHLORIDE INJECTION Naloxone Hydrochloride 2 clinical trials → |
Sandoz Canada Incorporated | Nonprescription Pharmaceutical Labelling Only |
22 Mar 2016 NOC 17912 |
| DEXEDRINE SPANSULES, DEXEDRINE TABLETS Dextroamphetamine Sulfate |
Paladin Labs Inc | Prescription Pharmaceutical Other |
22 Mar 2016 NOC 17906 |
| RAVICTI Glycerol Phenylbutyrate |
Horizon Pharma Ireland Ltd | Prescription Pharmaceutical Priority-NAS |
18 Mar 2016 NOC 17888 |
| LUNESTA Eszopiclone 2 clinical trials → |
Sunovion Pharmaceuticals Canada Inc | Prescription Pharmaceutical Other |
17 Mar 2016 NOC 17891 |
| IBRANCE Palbociclib 73 clinical trials → |
Pfizer Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) · with conditions |
16 Mar 2016 NOC 17885 |
| XTORO Finafloxacin |
Alcon Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
11 Mar 2016 NOC 17866 |
| BRIVLERA Brivaracetam 2 clinical trials → |
Ucb Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
9 Mar 2016 NOC 17859 |
| SUNVEPRA Asunaprevir |
Bristol-myers Squibb Canada | Prescription Pharmaceutical New Active Substance (NAS) |
9 Mar 2016 NOC 17856 |
| OPDIVO Nivolumab 268 clinical trials → |
Bristol-myers Squibb Canada | Biologic Priority |
26 Feb 2016 NOC 17814 |
| JADENU Deferasirox |
Novartis Pharmaceuticals Canada Inc | Prescription Pharmaceutical Other · with conditions |
24 Feb 2016 NOC 17792 |
| COTELLIC Cobimetinib 8 clinical trials → |
Hoffmann La Roche Limited | Prescription Pharmaceutical New Active Substance (NAS) |
22 Feb 2016 NOC 17786 |
| BRIDION Sugammadex 6 clinical trials → |
Merck Canada Inc | Prescription Pharmaceutical New Active Substance (NAS) |
5 Feb 2016 NOC 17744 |
| VIACORAM Perindopril Arginine, Amlodipine |
Servier Canada Inc | Prescription Pharmaceutical Other |
28 Jan 2016 NOC 17726 |
| KOVALTRY (ADAPTER), KOVALTRY (BIOSET) Antihemophilic Factor (recombinant) |
Bayer Inc | Biologic Other |
27 Jan 2016 NOC 17727 |
| ORKAMBI Ivacaftor, Lumacaftor |
Vertex Pharmaceuticals (canada) Incorporated | Prescription Pharmaceutical Priority-NAS |
26 Jan 2016 NOC 17725 |
| IDELVION Coagulation Factor Ix (recombinant), Albumin Fusion Protein (rix-fp), Albutrepenonacog Alfa |
Csl Behring Canada Inc | Biologic New Active Substance (NAS) |
26 Jan 2016 NOC 17715 |
| UPTRAVI Selexipag 4 clinical trials → |
Actelion Pharmaceuticals Ltd | Prescription Pharmaceutical New Active Substance (NAS) |
20 Jan 2016 NOC 17697 |
| ZEPATIER Grazoprevir, Elbasvir |
Merck Canada Inc | Prescription Pharmaceutical Priority-NAS |
19 Jan 2016 NOC 17681 |
| KYPROLIS Carfilzomib 46 clinical trials → |
Amgen Canada Inc | Prescription Pharmaceutical Priority-NAS |
15 Jan 2016 NOC 17669 |
| NATESTO Testosterone 7 clinical trials → |
Acerus Pharmaceuticals Srl | Prescription Pharmaceutical Other |
5 Jan 2016 NOC 17643 |
"New active substance" and "Priority" are Health Canada's submission classes. "With conditions" marks a Notice of Compliance with Conditions (NOC/c), granted on promising evidence while confirmatory studies continue.
| Company | Notices |
|---|---|
| Endo Operations Ltd. | 14 |
| Apotex Inc | 10 |
| Pfizer Canada Ulc | 7 |
| Jamp Pharma Corporation | 6 |
| Samsung Bioepis Co., Ltd | 6 |
| Celltrion Inc | 6 |
| Abbvie Corporation | 5 |
| Merck Canada Inc | 5 |
| Eli Lilly Canada Inc | 5 |
| Amgen Canada Inc | 5 |
| Sanofi-aventis Canada Inc | 5 |
| Astrazeneca Canada Inc | 4 |
| Glaxosmithkline Inc | 4 |
| Fresenius Kabi Canada Ltd | 4 |
| Biosimilar Collaborations Ireland Limited | 4 |
| Product | Company | Date |
|---|---|---|
| JAMP CALCITRIOL Calcitriol | Jamp Pharma Corporation | 18 Sep 2026 |
| PMS-LEVODOPA-CARBIDOPA CR Carbidopa, Levodopa | Pharmascience Inc | 18 Sep 2026 |
| MYPREF Levonorgestrel | Ambicare Pharmaceuticals Inc. | 18 Sep 2026 |
| SANDOZ SEMAGLUTIDE Semaglutide | Sandoz Canada Incorporated | 16 Sep 2026 |
| MINT-LAMOTRIGINE Lamotrigine | Mint Pharmaceuticals Inc | 16 Sep 2026 |
| TEVA-BILASTINE Bilastine | Teva Canada Limited | 15 Sep 2026 |
| MINT-SILDENAFIL R Sildenafil Citrate | Mint Pharmaceuticals Inc | 11 Sep 2026 |
| IBUPROFEN PLUS ACETAMINOPHEN Acetaminophen, Ibuprofen | Sun Pharma Canada Inc | 11 Sep 2026 |
| JAMP ACYCLOVIR Acyclovir | Jamp Pharma Corporation | 9 Sep 2026 |
| JAMP LEVETIRACETAM SOLUTION Levetiracetam | Jamp Pharma Corporation | 8 Sep 2026 |
| AURO-CARBAMAZEPINE Carbamazepine | Auro Pharma Inc | 3 Sep 2026 |
| JAMP TOBRAMYCIN / DEXAMETHASONE Dexamethasone, Tobramycin | Jamp Pharma Corporation | 1 Sep 2026 |
| JAMP METRONIDAZOLE GEL Metronidazole | Jamp Pharma Corporation | 28 Aug 2026 |
| TEVA-SACUBITRIL / VALSARTAN Valsartan, Sacubitril | Teva Canada Limited | 27 Aug 2026 |
| ACCEL-APREMILAST Apremilast | Accel Pharma Inc | 26 Aug 2026 |
| JAMP DOXEPIN TABLETS Doxepin Hcl | Jamp Pharma Corporation | 26 Aug 2026 |
| SEMAGLUTIDE INJECTION Semaglutide | Aspen Pharmacare Canada Inc. | 25 Aug 2026 |
| MINT-GALANTAMINE ER Galantamine Hydrobromide | Mint Pharmaceuticals Inc | 21 Aug 2026 |
| CARBOPLATIN INJECTION BP Carboplatin | Marcan Pharmaceuticals Inc | 20 Aug 2026 |
| TARO-DOXEPIN Doxepin Hcl | Taro Pharmaceuticals Inc | 19 Aug 2026 |
| PMS-ENZALUTAMIDE Enzalutamide | Pharmascience Inc | 14 Aug 2026 |
| BRIMONIDINE-TIMOLOL Timolol Maleate, Brimonidine Tartrate | Micro Labs Limited | 12 Aug 2026 |
| JAMP MIRTAZAPINE Mirtazapine | Jamp Pharma Corporation | 12 Aug 2026 |
| MINT-TADALAFIL Tadalafil | Mint Pharmaceuticals Inc | 12 Aug 2026 |
| SPC-ESTRADIOL 10 Estradiol Hemihydrate | Sun Pharma Canada Inc | 11 Aug 2026 |
| EUGIA-ABIRATERONE Abiraterone Acetate | Eugia Pharma Inc. | 7 Aug 2026 |
| NB-OLANZAPINE Olanzapine | Nb Pharma Inc. | 7 Aug 2026 |
| ODAN LIDOCAINE-PRILOCAINE CREAM Lidocaine, Prilocaine | Odan Laboratories Ltd | 6 Aug 2026 |
| APO-BILASTINE Bilastine | Apotex Inc | 6 Aug 2026 |
| M-IRBESARTAN Irbesartan | Mantra Pharma Inc. | 31 Jul 2026 |
| CYCLOPHOSPHAMIDE FOR INJECTION USP Cyclophosphamide Monohydrate | Formative Pharma Inc. | 31 Jul 2026 |
| MINOXIDIL 5% MEN / HOMMES Minoxidil | Nora Pharma Inc | 28 Jul 2026 |
| NAT-PALBOCICLIB Palbociclib | Natco Pharma (canada) Inc | 27 Jul 2026 |
| JAMP RAMIPRIL CAPSULES Ramipril | Jamp Pharma Corporation | 24 Jul 2026 |
| DEVATIS TOFACITINIB Tofacitinib Citrate | Devatis Canada Inc. | 21 Jul 2026 |
| ASPEN-SEMAGLUTIDE Semaglutide | Aspen Pharmacare Canada Inc. | 17 Jul 2026 |
| MINT-BRIVARACETAM Brivaracetam | Mint Pharmaceuticals Inc | 30 Jun 2026 |
| AURO-PERINDOPRIL/INDAPAMIDE Perindopril Erbumine, Indapamide | Auro Pharma Inc | 30 Jun 2026 |
| SEVMIA Semaglutide | Apotex Inc | 29 Jun 2026 |
| AURO-CLONIDINE Clonidine Hydrochloride | Auro Pharma Inc | 24 Jun 2026 |
| MAR-TEMOZOLOMIDE Temozolomide | Marcan Pharmaceuticals Inc | 23 Jun 2026 |
| GLN-NINTEDANIB Nintedanib Esylate | Glenmark Pharmaceuticals Canada Inc. | 22 Jun 2026 |
| SPC-GANIRELIX Ganirelix Acetate | Sun Pharma Canada Inc | 22 Jun 2026 |
| JAMP TACROLIMUS OINTMENT Tacrolimus | Jamp Pharma Corporation | 18 Jun 2026 |
| BUPIVACAINE HYDROCHLORIDE INJECTION USP Bupivacaine Hydrochloride | Hikma Canada Limited | 15 Jun 2026 |
| INFANTS' IBUPROFEN ORAL SUSPENSION Ibuprofen | Taro Pharmaceuticals Inc | 5 Jun 2026 |
| MINT-BILASTINE Bilastine | Mint Pharmaceuticals Inc | 4 Jun 2026 |
| JAMP NAPROXEN Naproxen | Jamp Pharma Corporation | 2 Jun 2026 |
| OLANZAPINE FOR INJECTION Olanzapine | Hikma Canada Limited | 29 May 2026 |
| PMS-VILAZODONE Vilazodone Hydrochloride | Pharmascience Inc | 29 May 2026 |
| ALTA-AZITHROMYCIN Azithromycin Dihydrate | Altamed Pharma | 26 May 2026 |
| BUPIVACAINE HYDROCHLORIDE INJECTION USP Bupivacaine Hydrochloride | Formative Pharma Inc. | 25 May 2026 |
| ZDS-IVERMECTIN CREAM Ivermectin | Zydus Lifesciences Limited | 13 May 2026 |
| MICAFUNGIN FOR INJECTION, USP Micafungin Sodium | Biocon Pharma Limited | 8 May 2026 |
| JAMP DICLOFENAC FOR SOLUTION Diclofenac Potassium | Jamp Pharma Corporation | 6 May 2026 |
| JAMP MIFEPRISTONE / MISOPROSTOL Mifepristone, Misoprostol | Jamp Pharma Corporation | 6 May 2026 |
| OCTREOTIDE DEPOT Octreotide | Sterimax Inc | 5 May 2026 |
| APO-SEMAGLUTIDE INJECTION Semaglutide | Apotex Inc | 1 May 2026 |
| SANDOZ DOLUTEGRAVIR Dolutegravir Sodium | Sandoz Canada Incorporated | 29 Apr 2026 |
| SEMAGLUTIDE INJECTION Semaglutide | Dr Reddys Laboratories Ltd | 28 Apr 2026 |
Showing the 60 most recent of 270 generic approvals.
Every row is copied from Health Canada's Notice of Compliance open data. Contains information licensed under the Open Government Licence - Canada. Health Canada has not endorsed this page.
A daily job downloads the full NOC dataset, keeps original new drug submissions (NDS) since 2016 and abbreviated (generic) submissions of the last 24 months, drops administrative notices and veterinary products, and joins each notice to its brand names and ingredients. No AI drafting and no editorial pass. See our editorial standards. The Health Canada data on this page was last retrieved on 27 Sep 2026.